2025-11-12T12:59:43+00:00 2024-12-31 346565596 ERNST & YOUNG US LLP ONE MANHATTAN WEST NEW YORK NY 100018604 990 2024-01-01 912154267 MEMORIAL SLOAN-KETTERING CANCER CENTER MEMO 6462273092 1275 YORK AVENUE NEW YORK NY 10065 SELWYN M VICKERS PRESIDENT & CHIEF EXECUTIVE 6462273092 2025-11-12 true Nicole Sokolowski P01683199 2127733000 2025-11-12 2024 2025-03-06 01:10:19Z SELWYN M VICKERS MD 1275 YORK AVENUE NEW YORK NY 10065 10946302638 true true 3475 X http://www.mskcc.org/ X LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. 117 105 25921 394 30239704 11156331 730582000 834084205 6306939000 7073995000 306904066 466316483 118198934 124838795 7462624000 8499234483 27561322 25488576 0 3711817811 3984115642 0 84766797 3449330265 3903744225 7188709398 7913348443 273914602 585886040 14659485000 15468483000 5422118000 5470776000 9237367000 9997707000 See schedule O false false 6480907372 10294000 6873948000 SEE SCHEDULE O 1071657211 19640642 200047000 SEE SCHEDULE O 257988231 3232186 SEE SCHEDULE O 7810552814 true true false true false false false false false true true true false false true false false true true true true false false false true false true true true true true true false false false false false false false false true true true false false false true true true true false false true 1360 0 true 25921 true true true false false false false true true false false false false true false X 117 105 true false false false true true false true true false false false true true true true true true true true false false AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X KEVIN MALARKEY 6462272638 1275 YORK AVENUE NEW YORK NY 100656007 DEBRA BERNS SVP & CHIEF RISK OFFICER 50.0 0 X X 1673783 0 48983 DOUGLAS A WARNER III SEE SCHEDULE O 7.0 0 X X 0 0 0 IAN COOK SEE SCHEDULE O 8.5 0 X X 0 0 0 JOHN R STRANGFELD SEE SCHEDULE O 5.0 0 X X 0 0 0 MARIE-JOSEE KRAVIS SEE SCHEDULE O 11.8 0 X X 0 0 0 MICHAEL HARRINGTON EVP & CHIEF FINANCIAL OFFICER 50.0 0 X X 2532398 0 70820 SCOTT M STUART SEE SCHEDULE O 15.8 0 X X 0 0 0 SELWYN VICKERS MD Board member, President & CEO 50.0 0 X X 6637012 0 342150 AARON BUNNER SEE SCHEDULE O 50.0 0 X 0 0 0 ALAN D SCHNITZER SEE SCHEDULE O 1.0 0 X 0 0 0 ALEXANDER T ROBERTSON SEE SCHEDULE O 3.0 0 X 0 0 0 ANKIT CHHABRA SEE SCHEDULE O 50.0 0 X 0 0 0 ANTHONY B EVNIN SEE SCHEDULE O 1.5 0 X 0 0 0 BENJAMIN W HEINEMAN JR SEE SCHEDULE O 3.0 0 X 0 0 0 BRUCE C RATNER SEE SCHEDULE O 2.0 0 X 0 0 0 CLIFTON S ROBBINS SEE SCHEDULE O 4.0 0 X 0 0 0 COLIN GARRY SEE SCHEDULE O 50.0 0 X 0 0 0 ELLEN V FUTTER SEE SCHEDULE O 2.3 0 X 0 0 0 GEOFFREY CANADA SEE SCHEDULE O 0.3 0 X 0 0 0 HENRY A FERNANDEZ SEE SCHEDULE O 3.0 0 X 0 0 0 JAMES G NIVEN SEE SCHEDULE O 3.0 0 X 0 0 0 JAMIE C NICHOLLS SEE SCHEDULE O 2.0 0 X 0 0 0 JONATHAN N GRAYER SEE SCHEDULE O 4.0 0 X 0 0 0 KATIE WELCH SEE SCHEDULE O 0.0 0 X 0 0 0 LOUIS V GERSTNER JR SEE SCHEDULE O 4.3 0 X 0 0 0 MARGARET KEANE SEE SCHEDULE O 7.0 0 X 0 0 0 PETER A WEINBERG SEE SCHEDULE O 5.0 0 X 0 0 0 PETER J SOLOMON SEE SCHEDULE O 2.0 0 X 0 0 0 RALPH MULLER SEE SCHEDULE O 2.0 0 X 0 0 0 RICHARD BEATTIE SEE SCHEDULE O 1.0 0 X 0 0 0 ROGER W FERGUSON SEE SCHEDULE O 4.0 0 X 0 0 0 SHIRLEY JACKSON SEE SCHEDULE O 0.3 0 X 0 0 0 SIMON POWELL MD CHAIRMAN ATTENDING 50.0 0 X 1900796 0 67875 STANLEY F DRUCKENMILLER SEE SCHEDULE O 3.0 0 X 0 0 0 STEPHEN C SHERRILL SEE SCHEDULE O 2.0 0 X 0 0 0 STEPHEN FRIEDMAN SEE SCHEDULE O 3.0 0 X 0 0 0 STEPHEN SQUERI SEE SCHEDULE O 3.0 0 X 0 0 0 VIRGINIA M ROMETTY SEE SCHEDULE O 4.0 0 X 0 0 0 WILLIAM E FORD SEE SCHEDULE O 3.0 0 X 0 0 0 WILLIAM HELMAN SEE SCHEDULE O 4.0 0 X 0 0 0 ANAEZE OFFODILE MD EVP, CHIEF STRATEGY OFFICER 50.0 0 X 1112462 0 42877 CAROLYN LEVINE ESQ VP, DEPUTY GENERAL COUNSEL & CORPORATE SECRETARY 50.0 0 X 591194 0 58320 ERIN MCDONOUGH EVP, MARKETING & COMMUNICATION OFFICER 50.0 0 X 1907439 0 47633 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 50.0 0 X 2271880 0 89901 JOAN MASSAGUE CHIEF SCIENTIFIC OFFICER & DIRECTOR OF SKI 50.0 0 X 2076081 0 91797 John Lasky EVP, CHIEF PEOPLE OFFICER 50.0 0 X 415498 0 27770 JORGE LOPEZ ESQ EVP & GENERAL COUNSEL 50.0 0 X 1675269 0 77943 KENNETH MANOTTI SVP & CHIEF DEVELOPMENT OFFICER 50.0 0 X 2074775 0 73984 LAKISHA MACK EVP, CHIEF ADMINISTRATIVE OFFICER 50.0 0 X 1179509 0 70199 LISA DEANGELIS MD CHIEF PHYSICIAN EXECUTIVE 50.0 0 X 2216824 0 81051 REMY EVARD EVP, CHIEF DIGITAL OFFICER 50.0 0 X 1613641 0 75600 SHELLY ANDERSON HOSPITAL PRESIDENT 50.0 0 X 2160092 0 64535 TRACY GOSSELIN SVP & Chief Nursing Executive 50.0 0 X 1021472 0 42637 BABAK MEHRARA MD CHIEF ATTENDING 50.0 0 X 2603794 0 88972 BERNARD BOCHNER ATTENDING, SURGERY 50.0 0 X 2375474 0 81382 JEFFREY DREBIN MD CHAIRMAN ATTENDING 50.0 0 X 2823914 0 84766 JONAS NELSON MD ASSOCIATE ATTENDING, SURGERY 50.0 0 X 2260579 0 51882 MICHELLE CORIDDI MD ASSOCIATE ATTENDING, SURGERY 50.0 0 X 2340489 0 56707 AMADOR CENTENO FORMER SVP FACILITIES MGMT & REAL ESTATE DEVELOPMENT 0.0 0 X 234230 0 9 CRAIG THOMPSON MD FORMER PRESIDENT & CEO 50.0 0 X 937871 0 53244 FREDRICK GROVES FORMER EVP HOSPITAL ADMINISTRATION 0.0 0 X 682010 0 29242 KATHRYN MARTIN FORMER CHIEF OPERATING OFFICER 0.0 0 X 1668982 0 28055 KERRY BESSEY FORMER SR VP/CHIEF HUMAN RESOURCES OFFICER 0.0 0 X 670892 0 18003 MARGARET BURKE SVP, PARTNERSHIP OPERATIONS (UNTIL 10/23) 0.0 0 X 566156 0 34324 MARK SVENNINGSON FORMER VP, FINANCE 0.0 0 X 800000 0 0 ROXANNE TAYLOR FORMER MARKETING OFFICER 0.0 0 X 239423 0 0 TOMYA WATT FORMER EVP, INTERIM CHIEF HUMAN RESOURCES OFFICER 50.0 0 X 1155056 0 73990 52418995 0 1974651 11213 true true false CANNON DESIGN ARCHITECTURE 300 E 42ND ST NEW YORK NY 10017 ARCHITECTURE 30649667 IMPACT ADVISORS LLC 400 E DIEHL RD NAPERVILLE IL 60563 FINANCIAL CONSULTANTS 28899419 JGN CONSTRUCTION CORP 66-40 69TH ST MIDDLE VILLAGE NY 11379 CONSTRUCTION 25163789 LEND LEASE US CONSTRUCTION 200 PARK AVE New YoRk NY 10166 CONSTRUCTION 14609898 EPIC SYSTEMS CORPORATION 1979 MILKY WAY VERONA WI 53593 SOFTWARE CONSULTANTS 14281411 198 4675205 303163000 526246000 17891697 834084205 MEDICAL CARE 622310 6873948000 6873948000 NON-GOVERNMENT SPONSORED RESEARCH 541711 200047000 200047000 0 0 0 0 7073995000 123943483 11156331 112787152 99511000 99511000 36575000 48617000 -12042000 0 -12042000 -12042000 2739726815 2397353815 342373000 0 342373000 342373000 212000 4675205 1097340 -885340 -885340 CARES ACT AND ALL OTHER 561439 20567135 19083373 1483762 Services Provided 561439 11149000 11149000 Cafeteria 722212 6539000 6539000 0 0 0 0 38255135 8499234483 7073995000 30239704 560915574 439576 439576 25049000 25049000 35425378 29530203 3526175 2369000 6443206 6443206 3083308187 3032309808 13676448 37321931 182241125 179034538 1185779 2020808 481897896 471534516 2445470 7917910 194799850 191386244 1262333 2151273 14961464 11905035 3056024 405 1087447 983873 103204 370 981667 981667 10196997 10196997 158593025 151489323 1537882 5565820 43242831 39953705 237126 3052000 379580866 355437523 2279205 21864138 141694584 140153180 183991 1357413 14119451 14119451 128814757 119382934 9299179 132644 14593463 14044803 162367 386293 16621809 15515884 143722 962203 132574400 132574400 436836966 432017931 4529912 289123 32909922 32520206 226378 163338 PHARMACEUTICALS 2033026062 2033026062 MEDICAL/SURGICAL SUPPLIES 392287306 392287306 UBIT EXPENSE 1335548 1335548 NET REQUISITION SERVICES 0 -11567560 11258092 309468 -49714340 0 -48617000 -1097340 7913348443 7810552814 18028832 84766797 X 12952793 3633255 9319538 675870000 604218000 1077070000 1320031000 559648000 675349000 707479000 850018000 0 0 0 0 85809000 95346000 142809000 165038000 503305000 440761000 9856912000 5290870000 4494401000 4566042000 4043625000 4084714000 2255698000 2511728000 0 113771000 155238000 14659485000 15468483000 1318024000 1401036000 3199911000 3166358000 0 0 88588000 74382000 815595000 829000000 5422118000 5470776000 X 7491133000 8059461000 1746234000 1938246000 9237367000 9997707000 14659485000 15468483000 X 585886040 239453000 -64999040 X false true true true true X X 4 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 131624182 4 true 0 0 MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASES 131624082 3 true 0 0 MEMORIAL SLOAN-KETTERING CANCER CENTER 131924236 3 true 0 0 LOUIS V GERSTNER JR GRADUATE SCHOOL OF BIOMEDICAL SCIENCES 202212588 2 true 0 0 4 0 0 446837895 702665000 656514020 686769000 792006205 3284792120 0 0 446837895 702665000 656514020 686769000 792006205 3284792120 152215322 3132576798 88008435 106284504 126987686 121449528 212488883 655219036 13946088 8274194 2466296 1713565 26400143 0 0 0 0 0 0 3966411299 29229052238 0.78978 0.78100 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0.0 X true false false false false false false false false false false false false false false true false Schedule A, Part I, Line 12g SUPPORTED ORGANIZATIONS SUPPORT FROM THE SUPPORTING ORGANIZATIONS RELATE PRINCIPALLY TO THE SHARING OF CERTAIN FACILITIES, EQUIPMENT, PERSONNEL COSTS, EDUCATION, INSURANCE AND ALLOCATIONS. AMOUNTS DUE TO OR DUE FROM AFFILIATES RESULTING FROM THESE SERVICES DO NOT BEAR INTEREST. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false false false false true 570297 false true 411370 981667 false Schedule C, Part II-B, Line 1i GREATER NEW YORK HOSPITAL ASSOCIATION $271,424 Schedule C, Part II-B, Line 1i american hospital association $57,751 Schedule C, Part II-B, Line 1i HOSPITAL ASSOCIATION OF NEW YORK $25,200 Schedule C, Part II-B, Line 1i ALLIANCE OF DEDICATED CANCER CENTERS $55,860 Schedule C, Part II-B, Line 1i OTHERS $1,135 1405130000 48529000 1876000 1455535000 1352022000 53289000 -181000 1405130000 1327922000 26784000 -2684000 1352022000 1228619000 96214000 3089000 1327922000 1208893000 19598000 128000 1228619000 0.4237 0.5763 0.0 false false 423134000 423134000 6529904000 3112760000 3417144000 47890000 37289000 10601000 2733489000 2125509000 607980000 122495000 15312000 107183000 4566042000 Closely-held equity interests Financial derivatives PRIVATE EQUITY & VENTURE CAPITAL 2511728000 F 2511728000 Federal Income Taxes POSTRETIREMENT OBLIGATIONS 96591000 INSURANCE RESERVES 336560000 DEFERRED COMPENSATION 100182000 Asset Retirement Obligation 38884000 Deferred Gift Annuity 11684000 Royalty Interest 85954000 Accrued Sick Pay 768000 Third-party settlement 158377000 829000000 8764579385 239453000 49918340 289371340 8475208045 24026438 24026438 8499234483 7942637345 53315340 53315340 7889322005 24026438 24026438 7913348443 Schedule D, Part V, Line 4 Intended uses of endowment funds PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 HOUSING EXPENSE OFFSET REVENUE - 48617000 EVENT EXPENSE OFFSET REVENUE - 1097340 MMPC SEPERATE 990 - 204000 - Schedule D, Part XI, Line 4(b) Other revenues in form 990 not in audited financial statements investment gross up - 24026438 Schedule D, Part XII, Line 2(d) Other expenses in audited financial statements not in form 990 HOUSING EXPENSES OFFSET REVENUE - 48617000 EVENT EXPENSES OFFEST REVENUE - 1097340 MMPC-SEPERATE 990 - 3601000 - Schedule D, Part XII, Line 4(b) Other expenses in form 990 not in audited financial statements investment costs gross up - 24026438 true true true true true true true false false false false false false false false false false true Schedule E, Part I, Line 3 RACIALLY NONDISCRIMINATORY POLICY SEE SCHEDULE E, PART II Schedule E, Part I, Line 3 NONDISCRIMINATORY POLICY THE SCHOOL'S NONDISCRIMINATORY POLICY IS PUBLICIZED ON ITS WEB SITE: HTTPS://WWW.SLOANKETTERING.EDU/GERSTNER/ADMISSIONS/REQUIREMENTS All applicants to the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences are considered on the basis ofmerit. In accordance with institutional policy and in compliance with the requirements of the Civil Rights Act, the Education Amendments, the Rehabilitation Act, the Age Discrimination Act, and the Americans with Disabilities Act, the school does notdiscriminate on the basis of age, genderidentity, gender expression, race, color, creed, religion, national origin, disability, veteran status, marital status,sex, sexual orientation, citizenship status or any other status protected by lawin the administration of its educational policies, admission policies, employment or any other GSK program or activity. EXCISE TAX ON NET INVESTMENT INCOME THE LOUIS V GERSTNER JR, GRADUATE SCHOOL OF BIOMEDICAL SCIENCES DOES NOT MEET THE CRITERIA OF SECTION 4968 AND, THEREFORE, IS NOT SUBJECT TO THE EXCISE TAX ON NET INVESTMENT INCOME. East Asia and the Pacific 0 4 Program Services ADMIN SUPPT CONFERENCES 32642 Europe (Including Iceland and Greenland) 0 18 Program Services ADMIN SUPPT CONEFRENCES 69932 South Asia 0 3 Program Services PATIENT CARE CONFERENCE 29188 Europe (Including Iceland and Greenland) 0 84 Program Services PATIENT CARE CONFERENCE 424992 Middle East and North Africa 0 6 Program Services PATIENT CARE CONFERENCE 43799 North America (Canada & Mexico only) 0 31 Program Services PATIENT CARE CONFERENCE 22352 East Asia and the Pacific 0 25 Program Services PATIENT CARE CONFERENCE 156323 Sub-Saharan Africa 0 15 Program Services PATIENT CARE CONFERENCE 32212 South America 0 9 Program Services PATIENT CARE CONFREENCE 33386 Europe (Including Iceland and Greenland) 0 73 Program Services RESEARCH CONFERENCE 182328 North America (Canada & Mexico only) 0 38 Program Services RESEARCH CONFERENCE 22990 East Asia and the Pacific 0 10 Program Services RESEARCH CONFERENCE 52658 Europe (Including Iceland and Greenland) 0 8 Program Services EDUCATIONAL CONFERENCE 18131 Central America and the Caribbean 0 0 Investments 2377222203 Sub-Saharan Africa 0 0 Investments 52022205 Europe (Including Iceland and Greenland) 0 0 Investments 51275755 South Asia 0 2 Program Services ADMIN SUPPORT CONFEERENCES 10037 Europe (Including Iceland and Greenland) 0 8 Program Services ADMINISTRATIVE SUPPORT 1327205 Central America and the Caribbean 0 1 Program Services ADMINISTRATIVE SUPPORT 85765 Middle East and North Africa 0 3 Program Services ADMINISTRATIVE SUPPORT 578720 Europe (Including Iceland and Greenland) 0 3 Program Services MEDICAL SUPPORT 49649 Middle East and North Africa 0 1 Program Services MEDICAL SUPPORT 333593 East Asia and the Pacific 0 1 Program Services RESEARCH SUPPORT 61182 Middle East and North Africa 0 1 Program Services RESEARCH SUPPORT 97611 Sub-Saharan Africa 0 2 Program Services RESEARCH SUPPORT 73732 South America 0 1 Program Services RESEARCH SUPPORT 66557 South America 0 1 Program Services ADMINISTRATIVE SUPPORT 117393 South Asia 1 Program Services ADMINISTRATIVE SUPPORT 162814 0 324 0 25 0 349 2481641096 2964258 2484605354 true false true true true false Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements CENTRAL AMERICA AND THE CARIBBEAN-Other: fmv,Cash; EAST ASIA AND THE PACIFIC-Cash; EUROPE (INCLUDING ICELAND AND GREENLAND)-Cash,Other: FMV; MIDDLE EAST AND NORTH AFRICA-Cash; NORTH AMERICA (CANADA & MEXICO ONLY)-Cash; SOUTH AMERICA-Cash; SOUTH ASIA-Cash; SUB-SAHARAN AFRICA-Cash,Other: FMV SPRING BALL 2143345 2078595 64750 150126 8600 189193 FALL PARTY 978374 965894 12480 153148 8900 86386 4 1765486 1630716 134770 261571 37834 78237 123345 4887205 4675205 212000 564845 37834 95737 398924 1097340 -885340 Schedule G, Part I, Line 3 The organization is registered or licensed to solicit contributions or has been notified it is exempt from registration or licensing in all states. true true X true X 500 true X 500 16684423 16684423 0.00211 508491364 297805766 210685598 0.02662 0 0.0 0 0 525175787 297805766 227370021 0.02873 14045038 253314 13791724 0.00174 257988231 71168681 186819550 0.02361 937330 84820 852510 0.00011 866087632 537783112 328304520 0.04149 514411 514411 0.00007 0 0 1139572642 609289927 530282715 0.06701 0 0 1664748429 907095693 757652736 0.09574 0 0.0 0 0.0 0 0.0 35072 35072 0.00000 0 0.0 1358171 1358171 0.00017 155782 155782 0.00002 215277 215277 0.00003 0 0.0 0 0 1764302 0 1764302 0.00022 false 119063173 2419958 1887924262 2409291235 -521366973 X true true 1 1 MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES 1275 York Avenue New York NY 10065 WWW.MSKCC.ORG 7002020H X X X X URGENT Care center see part v of schedule h MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES 1 false false true X X X X X X X X X 22 true false false true X WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS true 22 true WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS false true X 500.0 500.0 X X X X X X true true X X X X true X WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE X WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE X WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE X X X X X X X true X false X X X X true X false false Schedule H, Part V, Section B, Line 3E WE PRIORITIZED THE IDENTIFIED CANCER-RELATED COMMUNITY HEALTH NEEDS BASED ON CERTAIN CRITERION AS OUTLINED IN MSK'S 2022-2024 CHNA AND LINKED THEM TO APPROPRIATE PROGRAMS AND ACTIVITIES AS DESCRIBED IN THE IMPLEMENTATION STRATEGIES POSTED TO OUR WEBSITE AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS Schedule H, Part V, Section B, Line 5 Facility , 1 Facility , 1 - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES. TO UPDATE OUR UNDERSTANDING OF CURRENT CANCER-RELATED NEEDS WITHIN OUR CATCHMENT AREA, IN 2022 MSK INVITED COMMUNITY STAKEHOLDERS TO PARTICIPATE IN MSK'S COMMUNITY HEALTH NEEDS ASSESSMENT LEADERSHIP FORUM. INVITATIONS TO PARTNER IN OUR CHNA LEADERSHIP FORUM WERE SENT TO 225 COMMUNITY REPRESENTATIVES FROM WHICH 60 ORGANIZATIONS SERVING UNDERSERVED POPULATIONS PARTICIPATED. THESE ORGANIZATIONS ALSO HELPED DISSEMINATE THE GREATER NEW YORK HOSPITAL ASSOCIATION CHNA SURVEY TO THEIR AUDIENCES. PARTICIPANTS INCLUDED REPRESENTATIVES FROM COMMUNITY-BASED ORGANIZATIONS AND LOCAL HEALTH AGENCIES, LOCAL GOVERNMENT OFFICIALS, HEALTHCARE PROVIDERS, BUSINESSES, HEALTHCARE ADVOCATES, AND LABOR UNIONS. MSK'S VIRTUAL CHNA LEADERSHIP FORUM WAS HELD IN MAY 2022. PARTICIPANTS WERE ASSIGNED TO GROUPS RANGING IN SIZE BETWEEN 6-12 PEOPLE AND WERE ASKED TO SPEAK ON BEHALF OF THE DIVERSE LOCALIZED POPULATIONS THEIR ORGANIZATIONS AND AGENCIES SERVED INCLUDING HARLEM, QUEENS, BROOKLYN, NEW JERSEY, LONG ISLAND, AND WESTCHESTER. MSK'S CHNA COMMITTEE DEVELOPED A DISCUSSION GUIDE, WHICH SUPPORTED DEFINING CANCER-RELATED HEALTH PRIORITIES AND CONCERNS FACING AREA RESIDENTS (ESPECIALLY FOR DIVERSE AND MEDICALLY UNDERSERVED POPULATIONS) AND EXPLORING OPPORTUNITIES FOR MSK TO PARTNER WITH COMMUNITY-BASED ORGANIZATIONS TO ADDRESS HEALTH DISPARITIES. LEADING HEALTH NEEDS WERE IDENTIFIED BY GROUP CONSENSUS AND CATEGORIZED INTO FIVE BROAD AREAS FOR IMPROVING CANCER OUTCOMES: SOCIAL DETERMINANTS OF HEALTH, ACCESS TO CLINICAL SERVICES, LANGUAGE AND CULTURAL SENSITIVITY, SOCIAL SUPPORT AND COMMUNITY PARTNERSHIPS. AFTER THE FORUM, THE FINDINGS WERE SHARED WITH OUR CHNA PARTNERS FOR CONFIRMATION AND ADDITIONAL FEEDBACK. COMMUNITY ORGANIZATIONS THAT PROVIDED INPUT FOR MSK'S CHNA INCLUDE: A BETTER COLLEGE POINT CIVIC ASSOCIATION ADELPHI NY STATEWIDE BREAST CANCER HOTLINE AMERICAN CANCER SOCIETY ARAB AMERICAN ASSOCIATION OF NY ARAB AMERICAN FAMILY SUPPORT CENTER BREAST CANCER ALLIANCE BRONX HEALTH & HOUSING CONSORTIUM BRONX HEALTH REACH BROOKLYN COLLEGE CANCER CENTER BROTHER TO BROTHER CALLEN LORDE CANCER AND CAREERS CANCER CARE CANCER SUPPORT TEAM COALICION MEXICANA COUNCILWOMAN MERCEDES NARCISSE OFFICE, 46TH DISTRICT CSP OF NASSAU COUNTY DILIGENTLY SERVING IMMIGRANTS INC. GILDA'S - RED DOOR COMMUNITY GILDA'S CLUB OF WESTCHESTER HEADSTRONG FOUNDATION HOPE COMMUNITIES INC. LATINA SHARE LATINO COMMISSION ON AIDS - NYC REGION LEUKEMIA & LYMPHOMA SOCIETY LONG ISLAND NETS MAKE THE ROAD NY MEXICAN CONSULATE / VENTANILLA DE SALUD MIDDLESEX COUNTY OFFICE OF HEALTH SERVICES MOLLOY COLLEGE MONMOUTH COUNTY REGIONAL HEALTH COMMISSION NO. 1 NASSAU COUNTY DEPARTMENT OF HEALTH NASSAU LIBRARY SYSTEM NATIONAL ASSOCIATION OF NIGERIAN NURSES IN NORTH AMERICA NJCEED NOSTRAND GARDENS CIVIC ASSOCIATION NEW YORK CITY DISTRICT COUNCIL OF CARPENTERS OCEAN MONMOUTH HEALTH ALLIANCE OPEN DOOR FAMILY MEDICAL CENTERS RISEBOROUGH COMMUNITY PARTNERSHIPS RYE YMCA SISTERS UNITED IN HEALTH SOMERSET MORRIS CHRONIC DISEASE COALITION SOUL RYEDERS SOUTH ASIAN COUNCIL FOR SOCIAL SERVICES SUNNYSIDE COMMUNITY SERVICES SUPPORT CONNECTION SUSAN G. KOMEN BREAST CANCER ORGANIZATION THE ABYSSINIAN BAPTIST CHURCH THE BUSINESS COUNCIL OF WESTCHESTER THE COLETTE COYNE MELANOMA AWARENESS CAMPAIGN THE ISAACS CENTER AND GODDARD RIVERSIDE COMMUNITY CENTER UNION COUNTY OFFICE OF HEALTH MANAGEMENT UNION FOUTA UNIONDALE LIBRARY VISITING NURSES SERVICE OF NEW YORK - VNSNY CHOICE VNACJ COMMUNITY HEALTH CENTER WESTCHESTER JEWISH COMMUNITY SERVICES WYCKOFF HEALTH MEDICAL CENTER POSITIVE HEALTH MANAGEMENT MSK HELD A FOLLOW UP FORUM IN HARLEM IN AUGUST 2023 WITH COMMUNITY ORGANIZATIONS TO SHARE OUR IMPLEMENTATION PLAN AND INVITE FEEDBACK. THE FORUM GOALS WERE TO ALLOW MSK COMMUNITY PARTNERS TO PROVIDE FEEDBACK ON PROPOSED TACTICS IN THE 2022-2024 MSK COMMUNITY SERVICE PLAN, IDENTIFY EXISTING ALIGNED LOCAL PROGRAMS AND ORGANIZATIONS THAT MSK CAN PARTNER WITH IN ADVANCING THE TACTICS OF THE IMPLEMENTATION PLAN, AND PROVIDE A VENUE FOR NETWORKING AND CONNECTION BETWEEN MSK AND COMMUNITY ORGANIZATIONS. Schedule H, Part V, Section B, Line 7 Facility , 1 Facility , 1 - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES. SUMMARY FINDINGS OF MSK'S COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) WERE SENT TO COMMUNITY-BASED ORGANIZATIONS WITH WHOM WE WORKED AND INVITED THEIR FEEDBACK. WE ALSO INCORPORATED THE CHNA INTO OUR 2022-2024 NEW YORK STATE COMMUNITY SERVICE PLAN (CSP) TO ADDRESS THE IDENTIFIED HEALTH NEEDS. THE FINAL REPORT IS BEING SHARED VIA EMAIL WITH AREA OFFICIALS AND HEALTH AGENCIES, CIVIC LEADERS, AND COMMUNITY ORGANIZATIONS. IT IS ALSO PUBLISHED ON MSK'S WEBSITE FOR PUBLIC INFORMATION AND INPUT AT MSKCC.ORG/COMMUNITYSERVICEPLANS. MSK HELD A FOLLOW UP FORUM IN HARLEM IN AUGUST 2023 WITH COMMUNITY ORGANIZATIONS TO SHARE OUR IMPLEMENTATION PLAN AND INVITE FEEDBACK. THE FORUM GOALS WERE TO ALLOW MSK COMMUNITY PARTNERS TO PROVIDE FEEDBACK ON PROPOSED TACTICS IN THE 2022-2024 MSK COMMUNITY SERVICE PLAN, IDENTIFY EXISTING ALIGNED LOCAL PROGRAMS AND ORGANIZATIONS THAT MSK CAN PARTNER WITH IN ADVANCING THE TACTICS OF THE IMPLEMENTATION PLAN AND PROVIDE A VENUE FOR NETWORKING AND CONNECTION BETWEEN MSK AND COMMUNITY ORGANIZATIONS. MSK WILL MAKE ANNUAL UPDATES TO ITS COMMUNITY SERVICE PLAN WHENEVER REQUIRED BY THE NEW YORK DEPARTMENT OF HEALTH. Schedule H, Part V, Section B, Line 11 Facility , 1 Facility , 1 - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES. MSK HAS A LONG-STANDING COMMITMENT TO ADDRESS MANY OF THE CANCER-RELATED NEEDS IDENTIFIED THROUGH ITS RECENT CHNA. THE CHNA SURVEY DEVELOPED BY GNYHA AND DISSEMINATED TO COMMUNITY MEMBERS BY 14 HOSPITALS AND HEALTH SYSTEMS, INCLUDING MSK, CONFIRMED CANCER IS A LEADING CAUSE OF DEATH AND AN IMPORTANT CONCERN OF THE COMMUNITY. MSK'S COMMUNITY BENEFIT PROGRAMS WILL CONTINUE TO INCLUDE AN ARRAY OF CANCER-FOCUSED PROGRAMS AROUND RESEARCH, EDUCATION, PATIENT FINANCIAL ASSISTANCE, AND PATIENT SCREENING AND CARE. IN ADDITION, MSK WILL CONTINUE TO SUPPORT THE TOBACCO PREVENTION AND CHRONIC DISEASE PREVENTIVE CARE AND MANAGEMENT FOCUS AREAS OF THE NEW YORK STATE PREVENTION AGENDA. MSK IS CURRENTLY ADDRESSING MANY OTHER CANCER-FOCUSED TOPICS IDENTIFIED THROUGH THE CHNA, INCLUDING ACCESS TO CLINICAL SERVICES, SOCIAL DETERMINANTS OF HEALTH, AND LANGUAGE AND CULTURAL SENSITIVITY. FOR EXAMPLE, MSK'S RALPH LAUREN CENTER PROVIDES FREE AND DISCOUNTED CANCER CARE, PREVENTION, AND SCREENING, AS WELL AS HEALTH-RELATED AND NUTRITIONAL EDUCATION AT NO COST TO THE COMMUNITY. PROGRAMS THROUGH MSK'S IMMIGRANT HEALTH AND CANCER DISPARITIES SERVICE (IHCD) ADDRESS PREVENTION/SCREENING, NUTRITION EDUCATION, AND HEALTHCARE REFERRALS FOR IMMIGRANTS. THESE PROGRAMS INCLUDE THE ARAB HEALTH INITIATIVE, VENTANILLA DE SALUD (HEALTH WINDOW WITH MEXICAN CONSULATE), MOBILE HEALTH UNIT, AND THE TAXI NETWORK, AMONG OTHERS. IHCD ALSO RUNS THE FOOD TO OVERCOME OUTCOME DISPARITIES PROGRAM (F.O.O.D.), WHICH TACKLES FOOD INSECURITY AMONG UNDERSERVED CANCER PATIENTS BY PROVIDING NUTRITION EDUCATION AND FREE NUTRITIOUS FOODS THROUGH FOOD PANTRIES AT 15 CANCER TREATMENT SITES ACROSS NEW YORK CITY AND LONG ISLAND. F.O.O.D. PARTNERS WITH COMMUNITY-BASED ORGANIZATIONS, HOSPITALS AND OTHER AGENCIES TO CONDUCT RESEARCH ON THE IMPACT OF THE PROGRAM TO DECREASE FOOD INSECURITY AND INCREASE CANCER TREATMENT ADHERENCE AND PATIENT OUTCOMES. MSK'S TOBACCO TREATMENT PROGRAM (TTP) WORKS TO REDUCE TOBACCO-RELATED CANCER BURDENS AND ADDRESSES DISPARITIES THROUGH EVIDENCE-BASED CLINICAL CARE, EDUCATION, TRAINING, COMMUNITY OUTREACH, AND RIGOROUS RESEARCH. TO ADDRESS LANGUAGE ASSISTANCE FOR LIMITED ENGLISH PROFICIENCY PATIENTS, MSK ENSURES ALL PATIENTS AND FAMILIES ARE ABLE TO CONNECT TO HIGH-QUALITY CANCER CARE THROUGH MEDICAL INTERPRETING AND TRANSLATION SERVICES. MSK ALSO PRODUCES ONLINE AND PRINT RESOURCES IN MULTIPLE LANGUAGES, INCLUDING ALBANIAN, ARABIC, BENGALI, CHINESE, FRENCH, GERMAN, GREEK, GUJARATI, HEBREW, HINDI, ITALIAN, JAPANESE, KOREAN, POLISH, PORTUGUESE, PUNJABI, RUSSIAN, SPANISH, UKRAINIAN, URDU, VIETNAMESE, AND YIDDISH. ALL MATERIALS PRODUCED ARE AVAILABLE TO THE PUBLIC IN A VIRTUAL PATIENT EDUCATION LIBRARY AT MSKCC.ORG/PE. THE LIBRARY HOSTS OVER 5,000 EDUCATIONAL RESOURCES AND HAD OVER 88 MILLION VIEWS SINCE 2020. IN ADDITION, FOR MORE THAN 20 YEARS, MSK'S MEDICAL INTERPRETING TRAINING AND EDUCATION PROGRAM HAS ADDRESSED THE LANGUAGE BARRIERS IN HEALTHCARE BY TRAINING BILINGUAL INDIVIDUALS TO BECOME PROFESSIONAL MEDICAL INTERPRETERS. MEDICAL INTERPRETERS EMPOWER PROVIDERS TO DELIVER HIGH QUALITY, PERSONALIZED CARE WHILE ENSURING SATISFACTION AND MOST IMPORTANTLY, IMPROVED HEALTH OUTCOMES FOR PATIENTS. THE GNYHA SURVEY ADDITIONALLY IDENTIFIED DENTAL CARE, VIOLENCE, HEART DISEASE, AND COVID-19 AS TOP ISSUES. MSK WILL CONTINUE TO PARTNER WITH GOVERNMENT AGENCIES TO ADDRESS COVID-19 IF THE EPIDEMIC REQUIRES IT, BUT PROVIDING DENTAL CARE, AND PREVENTING VIOLENCE AND HEART DISEASE ARE NOT WITHIN MSK'S EXPERTISE TO ADDRESS. MSK PROVIDES REFERRALS TO EXTERNAL ORGANIZATIONS THAT RESPOND TO THESE NEEDS. ADDITIONAL INFORMATION ON IDENTIFIED NEEDS AND WHAT NEEDS ARE NOT BEING ADDRESSED TOGETHER WITH THE REASON WHY SUCH NEEDS ARE NOT BEING ADDRESSED CAN ALSO BE FOUND IN THE HOSPITAL'S MOST RECENT COMPREHENSIVE THREE-YEAR CSP AND CHNA REPORT POSTED AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. Schedule H, Part V, Section B, Line 13 Facility , 1 Facility , 1 - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES. WE USE A 500% OF THE FEDERAL POVERTY LEVEL (FPL) AS AN ANNUAL INCOME GUIDELINE. HOWEVER, WE MAY QUALIFY PATIENTS FOR OUR FAP EVEN IF THEIR INCOME EXCEEDS THE 500%. THAT'S BECAUSE WE ALLOW A DEDUCTION FOR MONTHLY ROUTINE HOUSEHOLD BILLS BASED ON FAMILY SIZE. PATIENTS WITH A ZERO OR NEGATIVE BALANCE ARE THEREFORE ELIGIBLE FOR THE PROGRAM UNLESS THEY HAVE LARGE ASSETS NOT LINKED TO THEIR RETIREMENT OR EDUCATION. Schedule H, Part V, Section B, Line 15 Facility , 1 Facility , 1 - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES. MSK IS COMMITTED TO PROVIDING FINANCIAL ASSISTANCE TO PATIENTS WITH THE GREATEST MEDICAL AND FINANCIAL NEEDS, INCLUDING UNINSURED AND UNDERINSURED PATIENTS WHO CANNOT AFFORD TO PAY FOR MEDICAL CARE OR WHO CANNOT ACCESS HEALTH INSURANCE. EACH APPLICATION FOR AID IS HANDLED CONFIDENTIALLY, IN COOPERATION WITH THE APPLICANT, AND IS DETERMINED BASED ON HOUSEHOLD INCOME AND FAMILY SIZE. HOSPITAL AND PHYSICIAN FEES ARE REDUCED OR TOTALLY FORGIVEN FOR QUALIFYING PATIENTS. TO HELP A BROAD RANGE OF PATIENTS, OUR INCOME ELIGIBILITY GUIDELINE FOR FREE CARE IS 500 PERCENT ABOVE THE FEDERAL POVERTY LEVEL, WELL ABOVE THE REQUIRED LEVEL OF 300 PERCENT. A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF THEIR INCOME EXCEEDS THE UPPER LIMIT. WE UNDERSTAND THAT EACH PATIENT HAS A UNIQUE FINANCIAL SITUATION AND ENCOURAGE PATIENTS TO CONTACT OUR FINANCIAL ASSISTANCE PROGRAM TO RECEIVE MORE INFORMATION. IN ADDITION, WE STRATEGICALLY PLACE FINANCIAL ASSISTANCE BROCHURES AT EACH REGISTRATION SITE AND AT THE FRONT DESK OF OUR PATIENT FINANCIAL SERVICES OFFICE. WE INCLUDE COPIES OF THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT. MENTION OF THE FAP IS MADE IN EVERY PATIENT STATEMENT AND LETTER SENT TO THEM. REFERENCE IS MADE IN THE COLLECTION LETTERS FROM COLLECTION AGENCIES AS WELL. FURTHERMORE, THE FINANCIAL ASSISTANCE INFORMATION IS POSTED ON THE MSK WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE Schedule H, Part V, Section B, Line 16 Facility , 1 Facility , 1 - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES. IN ADDITION TO BEING AVAILABLE ON OUR WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE, A PATIENT CAN ALSO REQUEST A COPY OF THE PLAIN LANGUAGE SUMMARY AND THE FAP APPLICATION BY CALLING OUR DEDICATED FINANCIAL ASSISTANCE LINE AT 212-639-3810. Schedule H, Part V, Section B, Line 20 Facility , 1 Facility , 1 - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES. REGARDING "PRESUMPTIVE ELIGIBILITY", HOSPITALS QUALIFY PATIENTS FOR CHARITY CARE AS PART OF THE BENEFIT THEY PROVIDE TO THE SURROUNDING COMMUNITIES. BY USING TECHNOLOGY THAT LEVERAGES CREDIT-SCORE-LIKE DATA, DEMOGRAPHIC INFORMATION AND SOCIAL MEDIA DATA, THEY DETERMINE WHETHER PATIENTS ARE LIKELY TO QUALIFY FOR CHARITY CARE. CURRENTLY, WE ARE NOT USING THIS TECHNOLOGY AT MSK; HOWEVER, WE DO SOMETIMES CONDUCT PRELIMINARY FINANCIAL SCREENINGS VIA TELEPHONE TO ASCERTAIN ELIGIBILITY FOR OUR FINANCIAL ASSISTANCE PROGRAM. ONCE THE PATIENT PROVIDES THE REQUIRED DOCUMENTS THE CASE IS FINALIZED. 5 MSK MONMOUTH 480 RED HILL ROAD MIDDLE TOWN NJ 07748 EXTENSION CLINIC MSK BERGEN 225 SUMMIT AVENUE MONTVALE NJ 07901 EXTENSION CLINIC MSK BASKING RIDGE 136 MOUNTAIN VIEW BLVD BASKING RIDGE NJ 07920 EXTENSION CLINIC MSK CLINICAL GENETICS SERVICES 222 EAST 70TH STREET NEW YORK NY 10021 EXTENSION CLINIC BENDHEIM CENTER FOR INTEGRATED MEDICINE 205 E64TH STREET NEW YORK NY 10065 EXTENSION CLINIC Schedule H, Part I, Line 3a A PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FEDERAL POVERTY GUIDELINES IS ELIGIBLE FOR THE INSTITUTION'S FINANCIAL ASSISTANCE PROGRAM (FAP). THE INSTITUTION MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. IN ADDITION, A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THE INSTITUTION ADJUSTS PATIENTS' INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE "DISPOSABLE INCOME". MSK ALSO DEDUCTS A SPECIFIC AMOUNT (DEBTBURDEN) AS A MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENT'S FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. THE TABLE BELOW ILLUSTRATES THE INCOME GUIDELINE USED IN EVALUATING THE PATIENT'S FINANCIAL STATUS. FAMILY SIZE; ALLOWED INCOME; RESOURCE LEVELS FAMILY SIZE; ALLOWED INCOME; RESOURCE LEVELS 1 $ 75,300 $ 60,364 2 $ 102,200 $ 81,642 3 $ 129,100 $102,920 4 $ 156,000 $124,198 5 $ 182,900 $145,476 6 $ 209,800 $166,754 7 $ 236,700 $188,032 8 $ 263,600 $209,310 Schedule H, Part I, Line 3c THE MAXIMUM AMOUNT CHARGED TO PATIENTS DEEMED ELIGIBLE UNDER THE FAP FOR "EMERGENCY OR OTHER MEDICALLY NECESSARY CARE" IS THE AMOUNT THE INSTITUTION INITIALLY CONCLUDED A PATIENT CAN AFFORD TO PAY WHEN FINALIZING THE FAP APPLICATION. THIS AMOUNT IS DERIVED BY CALCULATING A PATIENT'S HOUSEHOLD "NET MONTHLY INCOME DEDUCTING THE TOTAL AMOUNT OF ROUTINE MONTHLY BILLS. THE AMOUNT REMAINING IS WHAT WE CONSIDER THE PATIENT CAN PAY EACH MONTH. IF THE PATIENT'S HOUSEHOLD MONTHLY ROUTINE BILLS ARE MORE THAN OR EQUAL TO "NET MONTHLY INCOME", THE INSTITUTION ACCEPTS WHATEVER THE PATIENT'S INSURANCE PAYS AS PAYMENT IN FULL, (THE PATIENT WOULD NOT HAVE TO PAY ANYTHING OUT-OF-POCKET); UNLESS THE PATIENT HAS ASSETS SUCH AS A SECOND HOME, STOCKS, CERTIFICATE OF DEPOSITS, LARGE SAVINGS OR ANY OTHER ASSETS EXCLUDING RETIREMENT AND EDUCATION ACCOUNTS. PATIENTS WITH LARGE AMOUNTS OF ASSETS WHOSE ROUTINE MONTHLY BILLS ARE GREATER THAN THEIR "NET MONTHLY INCOME" MAY BE ELIGIBLE FOR REDUCED TIME AND PAYMENT ARRANGEMENT AND WOULD MAKE MONTHLY PAYMENTS (12 TO 18 MONTHS) TO PAY OFF THE AMOUNT THE INSTITUTION DETERMINED THEY CAN AFFORD TO PAY. ONCE THE FAP APPLICATION IS FINALIZED AND A PATIENT IS DEEMED ELIGIBLE TO PAY NOTHING OR A REDUCED TIME PAYMENT, THIS AGREEMENT IS EFFECTIVE FOR ONE YEAR AND INCLUDES THE PATIENT'S OUTSTANDING BALANCES. ALL PATIENTS ARE ADVISED OF MSK'S FAP, BUT AGAIN THE DETERMINATION IS ONLY DOCUMENTED IF THE PATIENT APPLIES FOR THE ASSISTANCE. Schedule H, Part I, Line 7 FINANCIAL ASSISTANCE REPRESENTS THE COST OF SERVICES PROVIDED TO PATIENTS WHO CANNOT AFFORD HEALTH CARE SERVICES DUE TO INADEQUATE RESOURCES AND/OR ARE UNINSURED OR UNDERINSURED. A PATIENT IS CLASSIFIED AS A FINANCIAL ASSISTANCE PATIENT IN ACCORDANCE WITH THE INSTITUTION'S ESTABLISHED POLICIES AND WHERE INSUFFICIENT PAYMENT FOR SUCH SERVICES IS ANTICIPATED. THE INSTITUTION CONSIDERS PATIENTS FOR FINANCIAL ASSISTANCE IF HOUSEHOLD INCOME IS LESS THAN 500% OF THE FEDERAL POVERTY GUIDELINES, AND AS DESCRIBED IN OTHER SECTIONS OF THIS DOCUMENT. SERVICES PROVIDED AS FINANCIAL ASSISTANCE ARE NOT REPORTED AS REVENUE. THE COSTS REPORTED IN THE TABLE ON LINE 7, WERE BASED ON VARIOUS SOURCES. FINANCIAL ASSISTANCE AND THE UNREIMBURSED MEDICAID COST WERE BASED ON A COST-TO-CHARGE RATIO CALCULATION. THE TOTAL CHARGES ASSOCIATED WITH THESE PROGRAMS ARE MULTIPLIED BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. THE COSTS ASSOCIATED WITH A PORTION OF THE HEALTH PROFESSIONAL EDUCATION COMMUNITY BENEFIT ARE OBTAINED FROM THE STEP-DOWN OF COSTS PREPARED AS PART OF THE NEW YORK STATE INSTITUTIONAL COST REPORT. TO ARRIVE AT THE AMOUNTS REPORTED IN THE TABLE ON LINE 7, ADDITIONAL STEPS AS OUTLINED BELOW WERE TAKEN. UNPAID COST OF GOVERNMENT-SPONSORED HEALTH CARE REPRESENTS THE ESTIMATED DIFFERENCE BETWEEN THE PAYMENTS MADE UNDER THE MEDICARE AND MEDICAID PROGRAMS AND THE INSTITUTION'S COST OF PROVIDING THESE SERVICES AS CALCULATED ABOVE. THE INSTITUTION SUBTRACTS ALL REVENUES RECEIVED FROM THE MEDICARE AND MEDICAID PROGRAMS TO DETERMINE THE COMMUNITY BENEFIT PROVIDED. RESEARCH COMMUNITY BENEFIT COSTS REPRESENT ALL COSTS FOR BASIC TRANSLATIONAL AND CLINICAL RESEARCH, SUPPORTED BY INSTITUTIONAL FUNDS, GOVERNMENTAL, AND OTHER NON-PROFIT ORGANIZATIONS. THE INSTITUTION IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTION TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS, RADIOLOGY STUDENTS, NURSING STUDENTS, SOCIAL WORK STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER BIOLOGY. THE AMOUNTS REPORTED AS HEALTH TRAINING REPRESENT INSTITUTIONAL FUNDS, AS WELL AS COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD-PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. AS INDICATED EARLIER, MSK'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL SERVICES AND OTHER QUALIFYING SUBSIDIZED COMMUNITY BENEFIT PROGRAMS TO PATIENTS. SUBSIDIZED CANCER SCREENINGS ARE ALSO OFFERED THROUGH OTHER COMMUNITY PROGRAMS PROVIDED BY THE INSTITUTION. THE COST ASSOCIATED WITH THESE PATIENTS' CARE ARE REPORTED IN THE TABLE ON LINE 7, BASED ON PATIENT CARE COST TO CHARGE RATIO, WHERE APPLICABLE. ALL SALARY EXPENSES RELATED TO OTHER SUBSIDIZED PATIENT CARE BY ATTENDING PHYSICIANS, CLINICAL AND RESEARCH FELLOWS AND NURSE PRACTITIONERS ARE ALSO REPORTED IN THE TABLE ON LINE 7G. Schedule H, Part II MSK ENGAGES IN AND SUPPORTS COALITION-BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR VARIOUS TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. Schedule H, Part I, Line 7g MEMORIAL SLOAN KETTERING HAS CONSISTENTLY SET THE STANDARD OF CARE FOR PEOPLE WITH CANCER BY EMPHASIZING EARLY DETECTION, PRECISE DIAGNOSIS, AND INDIVIDUALLY TAILORED TREATMENT. THE HOSPITAL SUBSIDIZES CANCER SCREENING, TREATMENT, AND SUPPORT SERVICES TO FULFILL ITS MISSION AND TO HELP REDUCE CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. MEMORIAL SLOAN KETTERING'S PSYCHIATRY & BEHAVIORAL SCIENCES DEPARTMENT IS COMMITTED TO THE URGENT AS WELL AS ROUTINE CARE OF PATIENTS WITH CANCER. OUR PSYCHIATRISTS AND PSYCHOLOGISTS HAVE EXPERTISE IN ASSISTING PATIENTS WITH THE SPECTRUM OF PSYCHIATRIC AND BEHAVIORAL ISSUES THAT CAN ARISE DURING DIAGNOSIS AND TREATMENT. THE DEPARTMENT ALSO WORKS TO DEEPEN ITS UNDERSTANDING AND EXPAND TREATMENT OPTIONS FOR ONCOLOGY PATIENTS AROUND THE GLOBE THROUGH CLINICAL TRIALS, RESEARCH, AND OTHER MEANS. TO ACCOMPLISH THESE GOALS, THE DIVISION OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL AND SOCIAL SUPPORT SERVICES TO PATIENTS, THEIR FAMILIES, AND CAREGIVERS. FUNDING FOR THE MEDICAID OUTPATIENT VISITS AND INPATIENT ENCOUNTERS ARE SUBSIDIZED BY MSK, AS ARE UNREIMBURSED TIME AND EFFORT BY NURSES TO STAFF A SMOKING CESSATION CLINIC. PHILANTHROPIC FUNDS ARE USED TO SUPPORT A SIGNIFICANT NUMBER OF THE DEPARTMENT'S OVERALL CLINICAL AND TRAINING ACTIVITIES. SERVICES PROVIDED INCLUDE CONSULTATIONS AND EVALUATION, PSYCHOTHERAPY, MEDICATION MANAGEMENT AND PHARMACOTHERAPY, SUPPORTIVE COUNSELING, SMOKING CESSATION, HYPNOTHERAPY, VARIOUS DIAGNOSTIC TESTS, AND OTHERS. DURING 2024, THE DEPARTMENT EXPERIENCED 32,163 INPATIENT AND OUTPATIENT ENCOUNTERS WITH 942 PATIENTS TREATED THROUGH THE SMOKING CESSATION PROGRAM. APPROXIMATELY $2.6M WAS EXPENDED BY THE DEPARTMENT TO SUPPORT ITS COMMUNITY BENEFIT-RELATED PROGRAMS, OF WHICH $392K, OR 11%, WERE INCURRED FOR SUBSIDIZED CLINICAL CARE. AT MSK WE BELIEVE IN CARING FOR THE WHOLE PERSON, NOT JUST THE DISEASE OR SYMPTOM. INTEGRATIVE MEDICINE WEAVES NATURAL TREATMENTS SUCH AS ACUPUNCTURE, MASSAGE, AND YOGA INTO OUR OVERALL CARE PLAN. ALL OF OUR HOLISTIC HEALTH SERVICES AND PROGRAMS ARE BASED ON THE LATEST SCIENTIFIC EVIDENCE. THE INTEGRATIVE MEDICINE SERVICE PROVIDES FREE CLINICAL CARE FOR INPATIENTS. DURING 2024, WE SERVED 3,623 PEDIATRIC INPATIENT VISITS. THESE CLINICAL SERVICES INCLUDED MUSIC THERAPY, TOUCH THERAPY, ACUPUNCTURE, YOGA AND YOGIC BREATHING, MEDITATION AND GUIDED IMAGERY, KARATE, AND DANCE THERAPY. WE ALSO PROVIDED EXTENSIVE EDUCATION FOR PATIENTS AND CAREGIVERS DURING BEDSIDE AND GROUP VISITS. THESE SERVICES ARE ALSO AVAILABLE FREE OF CHARGE TO PATIENTS SEEN ON THE OUTPATIENT PEDIATRIC FLOOR. DURING 2024, 889 OUTPATIENT PEDIATRIC VISITS WERE COMPLETED. IN ADDITION, WE OFFER OUTPATIENT ACUPUNCTURE CONSULTATIONS TO ANYONE IN THE COMMUNITY AT NO COST TO THEM. THESE CONSULTATIONS ADVISED CLIENTS ON HOW ACUPUNCTURE BENEFIT THEIR CONDITION BASED ON THEIR SPECIFIC THERAPEUTIC NEEDS. THERE WERE 66 ACUPUNCTURE CONSULTATIONS PROVIDED IN 2024. THE DEPARTMENT INCURRED $714M IN PERSONNEL COST TO DELIVER COMMUNITY BENEFIT-RELATED PROGRAMS. $161M OR 22.5% WERE SPENT ON SUBSIDIZED CLINICAL CARE THE BAD DEBT EXPENSE WAS NOT INCLUDED ON LINE 25 IN ACCORDANCE WITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (GAAP). Schedule H, Part V, Section B, Line 13 G NEW PATIENTS WHO RESIDE IN NEW YORK OR NEW JERSEY MAY QUALIFY FOR FINANCIAL ASSISTANCE. EXISTING PATIENTS MAY QUALIFY FOR AID REGARDLESS OF WHERE THEY LIVE IN THE UNITED STATES. Schedule H, Part V, Section B, Line 20 F NEITHER MSK NOR ITS COLLECTION AGENCIES PURSUE ANY EXTRAORDINARY COLLECTION ACTIONS AGAINST MSK'S PATIENTS. PRIOR TO REFERRING A PATIENT'S ACCOUNT TO A COLLECTION AGENCY MSK SENDS THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS MENTIONED IN EVERY PATIENT STATEMENT AND LETTER THAT IS SENT TO A PATIENT. THE FAP IS ALSO MENTIONED IN EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT'S ACCOUNT IS SENT TO COLLECTIONS, SHE/HE CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR FINANCIAL ASSISTANCE AND IF ELIGIBLE, RETROACTIVE FAP COVERAGE WOULD BE PROVIDED TO THE PATIENT. Schedule H, Part V, Section B, Line 21 ALL MSK'S PATIENTS REQUIRING URGENT CARE ARE PROVIDED WITH THE SERVICE REGARDLESS OF THEIR INSURANCE AND/OR FINANCIAL LIMITATION. FURTHERMORE, SERVICES ARE PROVIDED EVEN IF A DETERMINATION REGARDING ELIGIBILITY FOR MSK'S FAP HAS NOT YET BEEN MADE. THE MEMORIAL HOSPITAL URGENT CARE CENTER (UCC), OPEN SEVEN DAYS A WEEK, 24 HOURS A DAY, IS STAFFED AT ALL TIMES WITH AN ATTENDING PHYSICIAN. THE PRIMARY PURPOSE OF THE UCC IS TO TREAT REGISTERED MEMORIAL HOSPITAL PATIENTS WHO ARE ACUTELY ILL. THE UCC ALSO TREATS VISITORS WHO BECOME ACUTELY ILL ON THE PREMISES AND CANNOT BE TRANSFERRED TO NEW YORK PRESBYTERIAN/WEILL CORNELL MEDICAL CENTER, VISITORS WHO ARE INJURED ON THE PREMISES AND EMPLOYEES WHO BECOME ILL ON DUTY AFTER OUR EMPLOYEE HEALTH SERVICE HOURS. EXCEPT AS INDICATED ABOVE, THE UCC DOES NOT TREAT UNREGISTERED INDIVIDUALS WHO REPORT FOR TREATMENT BUT WILL EVALUATE THEIR CONDITION AND ADDRESS ACCORDINGLY. THE UCC COMPLIES WITH THE EMERGENCY TREATMENT AND ACTIVE LABOR ACT OF 1996 (42 USC SEC. 1395DD). Schedule H, Part VI Disclosures pursuant to Rev. Proc 2015-21 Amounts generally billed disclosure On October 29, 2024, MSKCC discovered that the hospital organization's amounts generally billed (AGB) statement ("AGB Statement") describing the look-back method it uses to determine AGB, which includes the applicable AGB percentages and describes the methodology used for calculating those percentages was missing from the hospital organization's financial assistance web page, and was not linked to/from the hospital organization's Financial Assistance Policy (FAP). Upon further inquiry, MSKCC determined that the AGB Statement had been missing from the hospital organization's financial assistance web page since October 2022, when it was moved to a different publicly-accessible web page within the FAP material. It was thought that changing the posted documents to a web page design would be a more logical presentation. At the same time, MSKCC discovered that the AGB Statement was not referenced in or linked to/from the FAP. As soon as MSKCC discovered this omission, MSKCC immediately began efforts to update and facilitate re-posting of the AGB Statement to the organization's financial assistance web page, and to ensure a hyperlink to the AGB Statement would be activated in the FAP. MSKCC re-posted the AGB Statement online, and activated the link to the AGB Statement in the FAP, in November 2024. To MSKCC and the hospital organization's knowledge, no individuals were adversely affected by this omission. To prevent recurrence of this omission, MSKCC will regularly monitor the FAP online and all FAP attachments and hyperlinked documents, including the AGB Statement, to ensure that they are up to date and that the hyperlinks in the FAP remain active. Non-employed provider list In mid-October 2024, MSKCC discovered that the hospital organization's list of non-employed providers of emergency or medically necessary care in its hospital facilities ("Provider List") was missing from the organization's financial assistance web page, and was not linked to from the organization's Financial Assistance Policy (FAP). The IRS discovered in doing a routine 501(r) compliance check that the Provider List was not referenced in or linked to the organization's FAP. As soon as MSKCC discovered this omission, MSKCC immediately began efforts to update and facilitate re-posting of the Provider List to the organization's financial assistance web page, and to ensure a hyperlink to the Provider List would be activated in the FAP which was done on November 14, 2024. To MSKCC's knowledge, no individuals were adversely affected by this omission. To prevent recurrence of this omission, MSKCC will regularly monitor the FAP online and all FAP attachments and hyperlinked documents, including the Provider List, to ensure that they are up to date and that the hyperlinks in the FAP remain active. Schedule H, Part III, Line 2 Bad debt expense - methodology used to estimate amount THE AMOUNT ON LINE 2 OF PART III IS THE ACTUAL 2024 BAD DEBT WRITE-OFF WHICH IS DERIVED BY TAKING THE GROSS CHARGES ASSOCIATED WITH THE PROVISIONS FOR BAD DEBTS AND MULTIPLYING BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. A SEPARATE RATIO IS CALCULATED FOR EACH TYPE OF PATIENT CARE ACTIVITY: INPATIENT, OUTPATIENT, AND PHYSICIAN Schedule H, Part III, Line 3 Bad Debt Expense Methodology PATIENTS CAN PURSUE FINANCIAL ASSISTANCE THROUGH MSK'S FINANCIAL ASSISTANCE PROGRAM. IF A PATIENT IS FOUND TO HAVE THE APPROPRIATE RESOURCES TO PAY FOR HEALTH SERVICES AND DOES NOT OR CHOOSES NOT TO PARTICIPATE IN AVAILABLE HEALTH BENEFIT PROGRAMS, THE INSTITUTION WILL BEGIN COLLECTION PROCEEDINGS IN ACCORDANCE WITH THE INSTITUTION'S POLICY. ONCE DEEMED UNCOLLECTABLE, THE CHARGES ARE CLASSIFIED AS BAD DEBTS AND ARE CHARGED OFF AS SUCH. THE AMOUNT ON LINE 3 OF PART III, REFLECTS THE COST OF THESE ACCOUNTS AS CALCULATED IN DETERMINING THE AMOUNT THAT REASONABLY COULD BE ATTRIBUTABLE TO PATIENTS WHO LIKELY WOULD QUALIFY FOR FINANCIAL ASSISTANCE UNDER THE INSTITUTION'S POLICY, THE INSTITUTION REVIEWED THE CASES THAT WERE CLOSED WITH AN "INCOMPLETE" STATUS IN THE FINANCIAL ASSISTANCE PROGRAM DURING 2020 THROUGH 2024. THE INSTITUTION THEN COMPARED THESE CASES AGAINST THE BAD DEBT WRITE-OFFS FROM 2024. Schedule H, Part III, Line 4 Bad debt expense - financial statement footnote THE INSTITUTION FOLLOWS GENERALLY ACCEPTED ACCOUNTING PRINCIPLES IN REPORTING ON BAD DEBT EXPENSES. THEREFORE, A DETAILED DESCRIPTION OF THE BAD DEBT POLICY IS NOT REQUIRED IN THE FOOTNOTES TO THE AUDITED FINANCIAL STATEMENTS. Schedule H, Part III, Line 8 Community benefit & methodology for determining medicare costs THE MEDICARE LOSS REFLECTS LOSSES FROM BOTH HOSPITAL AND PHYSICIANS' ACTIVITY. PHYSICIAN REVENUE IS SHOWN AS OTHER REVENUE ON THE MEDICARE COST REPORT. COSTS DISALLOWED BY THE MEDICARE PROGRAM, BUT WHICH ARE INCURRED IN PROVIDING CARE TO MEDICARE BENEFICIARIES HAVE BEEN INCLUDED. Schedule H, Part III, Line 9b Collection practices for patients eligible for financial assistance THE INSTITUTION DOES NOT PURSUE COLLECTIONS FROM PATIENTS APPLYING FOR FINANCIAL ASSISTANCE. IF, HOWEVER, COLLECTIONS WERE INITIATED, THE EFFORT IS IMMEDIATELY SUSPENDED WHEN THE PATIENT APPLIES FOR FINANCIAL ASSISTANCE. IF THE PATIENT QUALIFIES FOR THE FAP WITH ZERO FEE PAYMENT, THE INSTITUTION ACCEPTS AS FULL SETTLEMENT ANY AMOUNT PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. ADDITIONALLY, IF A PATIENT QUALIFIES FOR A TIME PAYMENT PLAN (TPP), ALL OTHER CHARGES APART FROM THE AGREED TPP AMOUNT IS WRITTEN OFF AS FINANCIAL ASSISTANCE. FOR EXAMPLE, IF THE AGREEMENT CALLS FOR THE PATIENT TO MAKE AN ANNUAL PAYMENT OF $2,400 ($200 MONTHLY), THEN ALL OTHER CHARGES ACCRUING TO THE PATIENT ARE CANCELED AND WRITTEN OFF AS FINANCIAL ASSISTANCE. ANNUALLY, THE PATIENT'S CASE IS REEVALUATED AND ADJUSTMENTS MADE BASED ON CHANGING CIRCUMSTANCES. Schedule H, Part V, Section B, Line 16a FAP website - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES: Line 16a URL: WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE; Schedule H, Part V, Section B, Line 16b FAP Application website - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES: Line 16b URL: WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE; Schedule H, Part V, Section B, Line 16c FAP plain language summary website - MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES: Line 16c URL: WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE; Schedule H, Part VI, Line 2 Needs assessment THE CHNA IS THE MEANS BY WHICH THE INSTITUTION ASSESSES THE HEALTH NEEDS OF THE COMMUNITY. SEE PART V, SECTION B Schedule H, Part VI, Line 3 Patient education of eligibility for assistance SINCE 1987, MSK HAS HAD A FINANCIAL ASSISTANCE PROGRAM IN PLACE TO ASSIST UNDERINSURED AND UNINSURED PATIENTS WHO ARE EXPERIENCING DIFFICULTIES MEETING THEIR FINANCIAL RESPONSIBILITIES TO MEMORIAL HOSPITAL AND ITS PHYSICIANS. FINANCIAL COUNSELORS WORK WITH PATIENTS AND INSURANCE COMPANIES INCLUDING MEDICARE AND MEDICAID TO HELP THE PATIENTS TO ACCESS SERVICES. THOSE WHO DO NOT QUALIFY FOR PUBLICLY AVAILABLE HEALTH INSURANCE, OR WHO ARE UNABLE TO PAY THEIR PORTION OF FEES ABOVE INSURANCE REIMBURSEMENT, MAY OBTAIN HELP THROUGH THE INSTITUTION'S FAP IF THEY ARE ELIGIBLE. THE PREMISE OF THE PROGRAM IS THAT ALL PATIENTS ARE EXPECTED TO CONTRIBUTE TO THEIR CARE BASED ON THEIR FINANCIAL ABILITY. THE FAP EMPLOYS SEVERAL STRATEGIES TO INCREASE PATIENTS' AWARENESS OF THE PROGRAM. DURING THE REGISTRATION PROCESS, FINANCIAL INTERVIEWERS EDUCATE PATIENTS ON THE VARIOUS PROGRAMS AVAILABLE TO THEM, INCLUDING GOVERNMENTAL PROGRAMS AND THE FINANCIAL ASSISTANCE PROGRAMS. MSK PERSONNEL SENDS THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS ALSO MENTIONED IN EVERY STATEMENT AND LETTER THAT IS SENT TO A PATIENT. MOREOVER, THE FAP IS AGAIN MENTIONED IN EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT'S ACCOUNT IS SENT TO COLLECTIONS, HE/SHE CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR FINANCIAL ASSISTANCE AND RETROACTIVE FAP COVERAGE WOULD BE GIVEN IF A PATIENT IS DETERMINED ELIGIBLE FOR ASSISTANCE. INFORMATION ABOUT THE FINANCIAL ASSISTANCE PROGRAM IS ALSO AVAILABLE ON THE INSTITUTION'S WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE OR BY CALLING OUR DEDICATED FINANCIAL ASSISTANCE LINE AT (212) 639-3810. Schedule H, Part VI, Line 4 Community information MSK'S INPATIENT HOSPITAL IS IN MID-MANHATTAN WITH ADDITIONAL OUTPATIENT TREATMENT CENTERS IN BROOKLYN, LONG ISLAND, WESTCHESTER COUNTY, AND NEW JERSEY. OUR PRIMARY CATCHMENT AREA ENCOMPASSES 23 COUNTIES ACROSS THE FIVE BOROUGHS OF NEW YORK CITY, LONG ISLAND, SOUTHERN NEW YORK STATE, NEW JERSEY, AND SOUTHWESTERN CONNECTICUT. A TOTAL OF 237,808 PATIENTS WERE SEEN AT MSK'S FACILITIES IN 2024, INCLUDING 215,805 (90.7 PERCENT) PATIENTS FROM THE TRISTATE AREA (NY, NJ, CT); 21,281 (8.9 PERCENT) PATIENTS FROM OTHER PARTS OF THE UNITED STATES. AND 722 (0.6 PERCENT) PATIENTS FROM OTHER COUNTRIES. THESE PATIENTS ACCOUNTED FOR 25,597 ADMISSIONS TO OUR HOSPITAL WITH 179,789 RELATED PATIENT DAYS AND 1,046,023 OUTPATIENT VISITS AT OUR COMBINED FACILITIES IN NEW YORK CITY AND THE REGION. Schedule H, Part VI, Line 5 Promotion of community health AT MSK, WE ARE UNITED BY A SINGULAR VISION - ENDING CANCER FOR LIFE. OUR SPECIALIZED CARE TEAMS PROVIDE PERSONALIZED, COMPASSIONATE, EXPERT CARE TO PATIENTS OF ALL AGES. INFORMED BY BASIC RESEARCH DONE AT OUR SLOAN KETTERING INSTITUTE, SCIENTISTS ACROSS MSK COLLABORATE TO CONDUCT INNOVATIVE TRANSLATIONAL AND CLINICAL RESEARCH THAT IS DRIVING A REVOLUTION IN OUR UNDERSTANDING OF CANCER AS A DISEASE AND IMPROVING THE ABILITY TO PREVENT, DIAGNOSE, AND TREAT IT. MSK IS DEDICATED TO TRAINING THE NEXT GENERATION OF SCIENTISTS AND CLINICIANS, WHO GO ON TO PURSUE OUR MISSION AT MSK AND AROUND THE GLOBE. AS ONE OF THE WORLD'S MOST RESPECTED COMPREHENSIVE CENTERS DEVOTED EXCLUSIVELY TO CANCER, WE HAVE BEEN RECOGNIZED AS ONE OF THE TOP TWO CANCER HOSPITALS IN THE COUNTRY BY U.S. NEWS & WORLD REPORT FOR MORE THAN 30 YEARS. WE ARE NOT JUST CAREGIVERS, BUT THE CAREGIVERS WHO MAKE THE DIFFERENCE IN THE DARKEST HOURS. WE PROVIDE MULTIDISCIPLINARY CARE, WHERE EXPERTS FROM MANY FIELDS OF MEDICINE COME TOGETHER TO DEVELOP THE BEST TREATMENTS FOR INDIVIDUAL PATIENTS AND FOR THE TREATMENT OF PATIENTS WITH ALL TYPES OF CANCER. THIS HAS ALLOWED US TO BE AT THE FOREFRONT OF DEVELOPING TREATMENTS THAT ARE MORE EFFECTIVE AT TREATING CANCER, WHILE AT THE SAME TIME SPARING MANY PATIENTS FROM THE MOST SERIOUS SIDE EFFECTS OF TREATMENT. HAVING THE SCIENTISTS WHO ASK AND ANSWER THE TOUGHEST QUESTIONS, OUR BASIC AND TRANSLATIONAL RESEARCHERS HAVE MADE MANY SIGNIFICANT CONTRIBUTIONS TO THE SCIENTIFIC COMMUNITY'S UNDERSTANDING OF CANCER BIOLOGY AND CANCER GENETICS AS WELL AS TO RELATED FIELDS OF CELL BIOLOGY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, DEVELOPMENTAL BIOLOGY, MOLECULAR PHARMACOLOGY AND CHEMISTRY, IMMUNOLOGY, COMPUTATIONAL BIOLOGY, AND DRUG DEVELOPMENT. GENES FIRST IDENTIFIED IN OUR LABORATORIES ARE NOW THE FOCUS OF INTENSE RESEARCH IN OTHER LABORATORIES AROUND THE WORLD. DRUGS, MONOCLONAL ANTIBODIES, AND OTHER AGENTS FIRST DEVELOPED IN OUR LABORATORIES HAVE GONE ON TO GAIN REGULATORY APPROVAL FOR TREATING PATIENTS WORLDWIDE. RECENT EXPANSION OF OUR LABORATORY SPACE HAS ALLOWED US TO GROW OUR RESEARCH EFFORTS SO THAT GOING FORWARD WE CAN CONTINUE TO MAKE DISCOVERIES THAT WILL CHANGE THE WAY THE WORLD UNDERSTANDS CANCER AND AID IN THE DEVELOPMENT OF BETTER TREATMENTS FOR CANCER PATIENTS EVERYWHERE. IN 2024, MSK SPENT $886.1M IN SUPPORT OF ITS RESEARCH MISSION, OF WHICH $ 313.0M WAS SPONSORED BY GOVERNMENTAL AND OTHER NON-PROFIT ORGANIZATIONS, $224.8M FROM PHILANTHROPY, AND $328.3M FROM THE INSTITUTION'S FUNDS. TRAINING THE NEXT GENERATION IS AN IMPORTANT EXAMPLE OF HOW THE INSTITUTION MAKES CONTRIBUTIONS TO THE CARE AND TREATMENT OF CANCER PATIENTS FAR BEYOND ITS OWN WALLS THROUGH WORKFORCE DEVELOPMENT. OUR TRAINING, GRADUATE, AND CONTINUING EDUCATION PROGRAMS PREPARE PHYSICIANS, SCIENTISTS, NURSES, AND TECHNICIANS TO BE LEADERS IN THEIR CHOSEN FIELDS. THESE HEALTHCARE PROVIDERS CAN THEN TAKE THE EXPERTISE GAINED FROM WORKING WITH OUR SPECIALISTS TO OTHER HEALTHCARE INSTITUTIONS AROUND THE COUNTRY AND THROUGHOUT THE WORLD. MSK ALSO TRAINS GRADUATE STUDENTS AND POSTDOCTORAL RESEARCHERS WORKING IN MANY AREAS OF BASIC SCIENCE AND TRANSLATIONAL RESEARCH. WHEN THESE YOUNG SCIENTISTS COMPLETE THEIR TRAINING; THEY BRING THE SKILLS OBTAINED IN OUR LABORATORIES INTO THE ACADEMIC COMMUNITY AT LARGE AS WELL AS THE PRIVATE SECTOR. MSK SPONSORS SEVERAL PROGRAMS THAT GIVE MEDICAL STUDENTS, UNDERGRADUATES, AND HIGH SCHOOL STUDENTS THE OPPORTUNITY TO WORK AT THE INSTITUTION DOING CLINICAL AND LABORATORY RESEARCH. THROUGH THESE PROGRAMS, MSK STRIVES TO INCREASE THE PIPELINE OF SCIENTISTS AND PHYSICIANS WORKING IN ONCOLOGY. IN 2020, THE INSTITUTION ESTABLISHED THE OFFICE OF HEALTH EQUITY ("OHE") TO ADDRESS CANCER OUTCOME DISPARITIES AND RELATED BARRIERS TO CARE AFFECTING DIFFERENT POPULATIONS AND COMMUNITIES. THE OHE IS RESPONSIBLE FOR LEADING AND SUPPORTING PATIENT CARE, RESEARCH, AND TRAINING ACTIVITIES THROUGHOUT THE INSTITUTION, ALL OF WHICH ARE DESIGNED TO PROMOTE FAIRNESS IN CANCER CARE AND OUTCOMES. THE OHE RESEARCH PROGRAM FOCUSES ON (I) ENSURING THAT VARIOUS POPULATIONS AND COMMUNITIES ARE EQUALLY REPRESENTED IN CANCER CLINICAL RESEARCH, AND (II) DEVELOPING A BETTER UNDERSTANDING OF DIFFERENT CANCER INCIDENCE RATES AND OUTCOMES IN GROUPS THAT TRADITIONALLY HAVE NOT BEEN WELL REPRESENTED IN CANCER CLINICAL RESEARCH. THE RESEARCH PROGRAM IS FOCUSED ON INCREASING ENROLLMENT OF THESE GROUPS IN THERAPEUTIC CLINICAL TRIALS AT MSK. INTEGRAL TO OHE'S ROLE IS THE DEVELOPMENT OF HEALTH EDUCATION AND TRAINING. AS SUCH, THE OHE HAS IMPLEMENTED RECRUITING AND TRAINING INITIATIVES ACROSS THE INSTITUTION. THE OBJECTIVE OF THESE PROGRAMS IS TO EXPAND THE PIPELINE OF PHYSICIANS AND SCIENTISTS WORKING IN ONCOLOGY SUCH THAT THEY REFLECT THE POPULATIONS AND COMMUNITIES BEING SERVED. OUR PROGRAMS PROVIDE CLINICAL RESEARCH AND LABORATORY RESEARCH OPPORTUNITIES FOR MEDICAL STUDENTS, UNDERGRADUATE STUDENTS, AND HIGH SCHOOL STUDENTS, EXPOSING THEM TO CUTTING-EDGE CANCER RESEARCH AND PAIRING THEM WITH RENOWNED MENTORS. MSK UTILIZED $258.M OF THE INSTITUTION'S RESOURCES DURING 2024 TO SUPPORT ITS EDUCATION AND TRAINING MISSION, WHICH WE CONSIDER VITAL, GIVEN OUR LEADERSHIP ROLE IN CANCER CARE TREATMENT AND RESEARCH. $71.2M OF THE AMOUNT WAS SPONSORED BY GOVERNMENTAL AND OTHER REVENUE SOURCES AND $187.0M FROM THE INSTITUTION'S GENERAL FUND. THE INSTITUTION HAS A BOARD FOR EACH OF THE SEVEN ENTITIES. AS OUTLINED IN SCHEDULE O, THERE IS A TOTAL OF 116 BOARD MEMBERS. MANY ARE MEMBERS OF MORE THAN ONE ENTITY'S BOARD AND THEREFORE, ARE COUNTED MORE THAN ONCE. THE GOVERNING BODY IS COMPRISED OF INDEPENDENT BOARD MEMBERS. ALL PHYSICIANS ARE ON STAFF AND ARE EMPLOYEES OF MSK, WITH LIMITED EXCEPTIONS. IN ITS PURSUIT TO FURTHER IMPROVE PATIENT CARE, MEDICAL EDUCATION, AND RESEARCH, THE INSTITUTION REINVESTS ANY SURPLUS FUNDS IN THE INSTITUTION'S POOL OF RESERVES. THESE RESERVES GENERATE INCOME TO SUPPORT FUTURE OPERATIONS AND RESTRICTED FUND SPENDING. BY PROVIDING FUNDING FOR OPERATIONS AND CAPITAL PROJECTS, IMPROVEMENTS TO PATIENT CARE, MEDICAL EDUCATION, AND RESEARCH ARE MADE POSSIBLE. EXPANDING OUR PRESENCE. IN 2023 THE INSTITUTION THROUGH ITS PHYSICIAN PRACTICE GROUP - MEMORIAL MEDICAL CARE PC. OPENED A FACILITY IN THE HEART OF BROOKLYN, BRINGING MSK'S WORLD-CLASS CANCER CARE DIRECTLY TO A BROADER PATIENT POPULATION, ENSURING GREATER ACCESS AND EQUITY TO PEOPLE IN BROOKLYN, QUEENS, AND THE BROADER NEW YORK METRO AREA AT A LOCATION THAT IS CLOSER TO HOME. WORKING ALONGSIDE THE NEW YORK CANCER & BLOOD SPECIALISTS TEAM, MSK PROVIDES PATIENTS ACCESS TO A WIDE RANGE OF SERVICES, INCLUDING ADVANCED IMAGING, STATE-OF-THE-ART THERAPIES, CUTTING-EDGE CLINICAL TRIALS, AND A MULTIDISCIPLINARY TEAM OF SPECIALISTS PROVIDING COLLABORATIVE PATIENT CARE AND DELIVERING THE BEST POSSIBLE OUTCOMES. PATIENTS REQUIRING COMPLEX CANCER CARE AND SURGERY HAVE DIRECT ACCESS TO MSK'S MAIN HOSPITAL IN MANHATTAN. Schedule H, Part VI, Line 6 Affiliated health care system THE ORGANIZATION IS NOT PART OF AN AFFILIATED HEALTH CARE SYSTEM. PLEASE SEE THE SUMMARY SECTION OF THE 990, ATTACHMENT 1 THROUGH ATTACHMENT 4 FOR FULL DETAILS ON THE ORGANIZATION'S STRUCTURE. Schedule H, Part VI, Line 7 State filing of community benefit report NY true American Cancer Society 3380 CHASTAIN MEADOW PKY KENNESAW GA 30144 131788491 501C(3) 75000 CANCER AWARENESS Food Pantry at Jamaica Hospital 8900 VAN WYCK EXPY RICHMOND HILL NY 11418 111631788 501C(3) 45000 CANCER AWARENESS Susan G Komen 901 EAST ST NW DC 20004 751835298 501C(3) 25000 CANCER AWARENESS New York Hall of Science 47-11 111 STREET CORONA NY 11368 112104059 501C(3) 20000 CANCER AWARENESS LGBT Network Pride 125 KENNEDY DRIVE HAUPPAUGE NY 11788 205929927 501C(3) 17500 CANCER AWARENESS Housing Help Inc 91 BROADWAY GREENLAWN NY 11740 112356150 501C(3) 15000 CANCER AWARENESS Big Brother Big Sister of America 25 CARLE RD WESTBURY NY 11590 231365190 501C(3) 15000 CANCER AWARENESS Salvation Army 992 PROSPECT AVE WESTBURY NY 11590 222406433 501C(3) 13000 CANCER AWARENESS The Hope Center 1401 UNIVERSITY AVE BRONX NY 10452 412040373 501C(3) 12000 CANCER AWARENESS Little Sisters of the Assumption 475 E 115 STREET New York NY 10029 132867881 501C(3) 10000 CANCER AWARENESS Green Bronx Machine 400 1ST AVE New York NY 10010 453303493 501C(3) 10000 CANCER AWARENESS Figure Skating in Harlem 361 W 125TH STREET New York NY 10027 133945168 501C(3) 10000 CANCER AWARENESS Breast Cancer Alliance 48 MAPLE AVE GREENWICH CT 06830 061453500 501C(3) 10000 CANCER AWARENESS Gilda's Club 80 MAPLE AVE WHITE PLAINS NY 10601 133939823 501C(3) 9600 CANCER AWARENESS Friends of Morningside Park Inc 14 MORNINGSIDE AVE New York NY 10026 133155238 501C(3) 9093 CANCER AWARENESS Volunteers of America 135W 50TH STREET New York NY 10020 131692595 501C(3) 8339 CANCER AWARENESS Harlem Pride 42 MACOMBS PLACE New York NY 10039 272191962 501C(3) 7000 CANCER AWARENESS Abyssinian Baptist Church 132 W 138 STREET New York NY 10030 131635250 501C(3) 6600 CANCER AWARENESS PS 183 Parents Teachers Assoc Inc 419 E 66TH STREET New York NY 10065 133897940 501C(3) 6500 CANCER AWARENESS Harlem Youth Baseball Assoc Inc PO BOX 5540 New York NY 10027 272104622 501C(3) 6000 CANCER AWARENESS 20 0 STIPENDS 449 25049000 Schedule I, Part III FOR THE YEAR 2024, THE AMOUNT REPORTED IS FOR STIPENDS PAID TO 225 RESEARCH FELLOWS AND 224 GRADUATE STUDENTS. EDUCATION AND TRAINING INCLUDE CLASSROOM INSTRUCTIONS WITH HANDS-ON EXPERIENCE IN BOTH RESEARCH LABORATORIES AND CLINICAL CARE ACTIVITIES. THE AFOREMENTIONED GRANTEES ARE REQUIRED TO BE IN COMPLIANCE WITH ACADEMIC REQUIREMENTS. THIS INCLUDES DIRECT SUPERVISION AND DIRECTION BY PHYSICIANS AND RESEARCH INVESTIGATORS. Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds IN THE CASE OF MOST DONATIONS OF $5,000 OR MORE TO ORGANIZATIONS IN ORDER TO MAKE THE PUBLIC AWARE OF CANCER CARE, WRITTEN AGREEMENTS ARE IN PLACE AND WE HAVE REGULAR CONTACT WITHTHOSE ORGANIZATIONS TO ASSURE THAT THE DONATIONS ARE BEING USED AS AGREED UPON. THE RECORDS ARE EITHER MAINTAINED IN ADMINISTRATION. X X true true X X X X X true false false false false false false true true true DEBRA BERNS SVP & CHIEF RISK OFFICER 757276 0 910850 0 5657 0 27600 0 21383 0 1722766 0 0 0 MICHAEL HARRINGTON EVP & CHIEF FINANCIAL OFFICER 1521342 0 972449 0 38607 0 27600 0 43220 0 2603218 0 0 0 SELWYN VICKERS MD Board member, President & CEO 3057201 0 3475000 0 104811 0 27600 0 314550 0 6979162 0 0 0 SIMON POWELL MD CHAIRMAN ATTENDING 1389189 0 481889 0 29718 0 27600 0 40275 0 1968671 0 0 0 SHELLY ANDERSON HOSPITAL PRESIDENT 1835050 0 319660 0 5382 0 27600 0 36935 0 2224627 0 0 0 LISA DEANGELIS MD CHIEF PHYSICIAN EXECUTIVE 1341831 0 845325 0 29668 0 27600 0 53451 0 2297875 0 0 0 REMY EVARD EVP, CHIEF DIGITAL OFFICER 828629 0 778335 0 6677 0 27600 0 48000 0 1689241 0 0 0 TRACY GOSSELIN SVP & Chief Nursing Executive 788166 0 230170 0 3136 0 27600 0 15037 0 1064109 0 0 0 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 1159470 0 1000000 0 112410 0 27600 0 62301 0 2361781 0 0 0 John Lasky EVP, CHIEF PEOPLE OFFICER 285662 0 125000 0 4836 0 19844 0 7926 0 443268 0 0 0 CAROLYN LEVINE ESQ VP, DEPUTY GENERAL COUNSEL & CORPORATE SECRETARY 488178 0 92458 0 10558 0 17250 0 41070 0 649514 0 0 0 JORGE LOPEZ ESQ EVP & GENERAL COUNSEL 1013154 0 639505 0 22610 0 27600 0 50343 0 1753212 0 0 0 LAKISHA MACK EVP, CHIEF ADMINISTRATIVE OFFICER 821907 0 355438 0 2164 0 27600 0 42599 0 1249708 0 0 0 KENNETH MANOTTI SVP & CHIEF DEVELOPMENT OFFICER 943478 0 1098776 0 32521 0 27600 0 46384 0 2148759 0 0 0 JOAN MASSAGUE CHIEF SCIENTIFIC OFFICER & DIRECTOR OF SKI 1218698 0 660000 0 197383 0 27600 0 64197 0 2167878 0 0 0 ERIN MCDONOUGH EVP, MARKETING & COMMUNICATION OFFICER 786917 0 1111500 0 9022 0 27600 0 20033 0 1955072 0 0 0 ANAEZE OFFODILE MD EVP, CHIEF STRATEGY OFFICER 811569 0 299485 0 1408 0 27600 0 15277 0 1155339 0 0 0 BERNARD BOCHNER ATTENDING, SURGERY 908560 0 1400000 0 66914 0 27600 0 53782 0 2456856 0 0 0 MICHELLE CORIDDI MD ASSOCIATE ATTENDING, SURGERY 1647692 0 684101 0 8696 0 27600 0 29107 0 2397196 0 0 0 JEFFREY DREBIN MD CHAIRMAN ATTENDING 2594196 0 200000 0 29718 0 27600 0 57166 0 2908680 0 0 0 BABAK MEHRARA MD CHIEF ATTENDING 2516268 0 50000 0 37526 0 27600 0 61372 0 2692766 0 0 0 JONAS NELSON MD ASSOCIATE ATTENDING, SURGERY 1671268 0 569391 0 19920 0 27600 0 24282 0 2312461 0 0 0 KERRY BESSEY FORMER SR VP/CHIEF HUMAN RESOURCES OFFICER 54051 0 0 0 616841 0 4568 0 13435 0 688895 0 0 0 AMADOR CENTENO FORMER SVP FACILITIES MGMT & REAL ESTATE DEVELOPMENT 0 0 0 0 234230 0 0 0 9 0 234239 0 0 0 FREDRICK GROVES FORMER EVP HOSPITAL ADMINISTRATION 0 0 0 0 682010 0 0 0 29242 0 711252 0 0 0 ROXANNE TAYLOR FORMER MARKETING OFFICER 0 0 0 0 239423 0 0 0 0 0 239423 0 0 0 CRAIG THOMPSON MD FORMER PRESIDENT & CEO 721670 0 216201 0 0 0 0 0 53244 0 991115 0 0 0 TOMYA WATT FORMER EVP, INTERIM CHIEF HUMAN RESOURCES OFFICER 511151 0 403000 0 240905 0 27600 0 46390 0 1229046 0 0 0 MARGARET BURKE SVP, PARTNERSHIP OPERATIONS (UNTIL 10/23) 0 0 0 0 566156 0 0 0 34324 0 600480 0 0 0 KATHRYN MARTIN FORMER CHIEF OPERATING OFFICER 0 0 179619 0 1489363 0 0 0 28055 0 1697037 0 0 0 MARK SVENNINGSON FORMER VP, FINANCE 0 0 0 0 800000 0 0 0 0 0 800000 0 0 0 Schedule J, Part I, Line 1a First-class or charter travel BUSINESS OR FIRST-CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. Schedule J, Part I, Line 1a Housing allowance or residence for personal use THE INSTITUTION REQUIRES THE PRESIDENT TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. Schedule J, Part I, Line 4a Severance or change-of-control payment INCLUDED IN FORM 990 IS SEVERANCE PAY: KATHRYN MARTIN $1,489,363 FREDRICK GROVES $ 668,752 AMADOR CENTENO $ 234,230 KERRY BESSY $ 531,016 ROXANNE TAYLOR $ 239,423 TOMYA WATT $ 139,050 MARGARET BURKE $ 572.777 Schedule J, Part I, Line 7 Non-fixed payments INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF PRE-DETERMINED GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. THE COMPENSATION COMMITTEE OF THE BOARD AUTHORIZES ALL EXECUTIVE BONUSES AND INCENTIVE PLANS ON AN ANNUAL BASIS. Schedule J, Part I, Line 8 Payments on contract that is subject to the initial contract exception AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-04-28 110000000 2016 SERIES BONDS WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES. false false false B NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2016-09-09 145000000 2016 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. false false false C DOMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2017-12-20 335567386 2017 SERIES BONDS WERE USED TO CURRENT REFUND THE 2015 SERIES BONDS & CONSTRUCT VARIOUS FACILITIES false false false D DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 64990GVG4 2019-11-01 342248699 2019 SERIES BONDS WERE USED TO REIMBURSE EXPENDITURES INCURRED TO CONSTRUCT A PATIENT CARE FACILITY. false false false A 30479563 110239999 155282 110009717 75000 2017 false false true true B 119625000 145000000 72861 144627139 300000 2018 false false true true C 29970000 339194534 2262236 245499309 91432989 2019 true false true true D 342248699 2248699 340000000 2019 false false true true A false false false false true false 0.0 0.0 0.0 false false 0 false true B false false false false true false 0.0 0.0 0.0 false false 0 false true C false false false false true false 0.0 0.0 0.0 false false 0 false true D false false false false true false 0.0 0.0 0.0 false false 0 false true A false false false true false false 0 false false false 0 false false true B false false false true false false 0 false false false 0 false false true C false false false true false false 0 false false false 0 false false true D false true false false false false 0 false false false 0 false false true A true B true C true D true Schedule K, Part II Line 3 04/28/2016, 12/20/2017, 06/28/2022, and 08/01/2022 BOND ISSUES: TOTAL PROCEEDS OF THE ISSUE DOES NOT EQUAL ISSUE PRICE DUE TO INVESTMENT EARNINGS EARNED DURING THE PROJECT PERIOD. Schedule K, Part IV, Line 2c COLUMN A Issuer name: DORMITORY AUTHORITY OF THE STATE OF NEW YORK The calculation for computing no rebate due was performed on 05/19/2023 Schedule K, Part IV, Line 2c COLUMN B Issuer name: NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY The calculation for computing no rebate due was performed on 07/06/2022 Schedule K, Part IV, Line 2c COLUMN C Issuer name: DOMITORY AUTHORITY OF THE STATE OF NEW YORK The calculation for computing no rebate due was performed on 03/17/2023 A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 65000BPS1 2022-06-28 199996589 2022 SERIES #1 BONDS WERE USED TO RENOVATE VARIOUS LOCATIONS - HOSPITAL AND OUTPATIENT FACILITIES A false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2022-08-01 100000000 2022 SERIES #2 BONDS WERE USED TO RENOVATE NON-PATIENT SPACE. false false false A 200507663 1220622 199162041 125000 2022 false false true true B 104083394 227400 83417822 15000 20423172 false false false true A false false false false true false 0.0 0.0 0.0 false false 0 false true B false false false false true false 0.0 0.0 0.0 false false 0 false true A false true false false false false 0 false false false 0 false false true B false true false false false false 0 false false false 0 false false true A true B true MEMORIAL MEDICAL CARE PC SEE PART V 3601411 MANAGEMENT AGREEMENT false DR T LINDSTEN SEE PART V 145882 FAMILY EMPLOYMENT false JESSICA ROSS SEE PART V 97012 FAMILY EMPLOYMENT false Schedule L, Part IV 1 DR. LISA DEANGELIS IS THE CHIEF PHYSICIAN EXECUTIVE OF THE ORGANIZATION. IN SUCH A CAPACITY, SHE IS A 75% OWNER OF MEMORIAL MEDICAL CARE PC (MMPC). MMPC IS A SECTION 501(C)(3) TAX-EXEMPT CAPTIVE MEDICAL GROUP. MMPC OPERATES A FACILITY IN BROOKLYN WHERE PATIENTS HAVE ACCESS TO A WIDE RANGE OF SERVICES, INCLUDING ADVANCED IMAGING, STATE-OF THE-ART THERAPIES, CUTTING-EDGE CLINICAL TRIALS, AND A MULTIDISCIPLINARY TEAM OF SPECIALISTS. THE AMOUNT REPORTED IN PART IV, $3,601,411, IS THE NET COSTS FOR SUCH SERVICES IN 2024. Schedule L, Part IV THE INDIVIDUALS LISTED WERE NOT A PARTY TO THE TRANSACTIONS. THERE IS NO SHARING OF THE INSTITUTE'S REVENUE. THE PURCHASE OF GOODS AND SERVICES BY THE INSTITUTION WERE MADE IN THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS, AT COMMERCIALLY AVAILABLE RATES NORMALLY CHARGED TO OTHERS. Schedule L, Part IV 2 DR. CRAIG THOMPSON WAS THE PRESIDENT OF THE INSTITUTION UNTIL SEPTEMBER 2022. HIS SPOUSE, DR. TULLIA LINDSTEN, IS A LABORATORY MEMBER FOR SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. HER COMPENSATION, FOR 2024 WAS $145,882. Schedule L, Part V 4 SCOTT STUART IS A BOARD MEMBER OF MEMORIAL HOSPITAL. HIS DAUGHTER, JESSICA ROSS, IS A FELLOW AT MEMORIAL HOSPITAL. HER COMPENSATION FOR 2024 WAS $97,012. 191 17891697 Market value 0 false true true Schedule M, Part I, Line 32b Third parties used to solicit, process, or sell noncash contributions PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. Schedule M, Part I Explanations of reporting method for number of contributions Securities - Publicly traded - NUMBER OF CONTRIBUTIONS Form 990, Part III, Line 1 MISSION THE MISSION OF MEMORIAL SLOAN-KETTERING CANCER CENTER IS TO LEAD IN THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF CANCER AND ASSOCIATED DISEASES THROUGH PROGRAMS OF EXCELLENCE IN RESEARCH, EDUCATION, OUTREACH AND COST-EFFECTIVE PATIENT CARE. LEADERSHIP IN PATIENT CARE: WE PLACE THE HIGHEST PRIORITY ON ADVANCING THE CARE OF CANCER PATIENTS THROUGH EARLY DETECTION, ACCURATE DIAGNOSIS, AND OPTIMAL TREATMENT. THESE THREE ELEMENTS LEAD TO THE MOST EFFECTIVE CANCER CARE POSSIBLE, WHICH IS ALSO THE MOST COST-EFFECTIVE CARE. WE STRIVE FOR EXCELLENCE IN ALL EXISTING AND EMERGING THERAPIES WITHOUT NEGLECTING THE NEED FOR ADVANCED APPROACHES IN PALLIATION. WE DELIVER THESE THERAPIES IN A CARING ENVIRONMENT THAT ENCOMPASSES PATIENTS AS WELL AS THEIR LOVED ONES. EXCELLENCE IN PATIENT CARE IS EXEMPLIFIED BY OUR MULTIDISCIPLINARY APPROACH, A CORE COMPETENCE OF OUR CENTER. WE ARE COMMITTED TO DEVELOPING OUTREACH PROGRAMS TO BRING EXCELLENCE IN CANCER CARE TO THE COMMUNITY. LEADERSHIP IN RESEARCH EXCELLENCE: PATIENT CARE REQUIRES THE EXPEDITIOUS APPLICATION OF NEW KNOWLEDGE DISCOVERED THROUGH RIGOROUS LABORATORY AND CLINICAL RESEARCH. THE INTERRELATIONSHIP BETWEEN SCIENTIFIC DISCOVERY AND ITS APPLICATION TO PATIENT CARE DEFINES OUR UNIQUE NATURE AT ITS BEST. LEADERSHIP IN EDUCATION: TO ENSURE PROGRESS, WE ARE DEDICATED TO PROVIDING THE FINEST EDUCATION AND TRAINING FOR THE MOST PROMISING YOUNG SCIENTISTS, CLINICIANS, AND OTHER HEALTHCARE PROFESSIONALS. PUBLIC AND PATIENT EDUCATION ARE ALSO CORNERSTONES FOR PROGRESS AND SUCCESS IN PATIENT CARE, ESPECIALLY IN PREVENTION, EARLY DETECTION, AND COMPLIANCE DURING THERAPY AND MAINTENANCE PROGRAMS. RESOURCES FOR LEADERSHIP: WE ARE STAFFED WITH THE HIGHEST-QUALITY PROFESSIONALS WHO HAVE A FULL-TIME COMMITMENT TO OUR MISSION. WE ARE DETERMINED TO PROVIDE OUR STAFF AND OUR PATIENTS WITH THE FINEST STATE-OF-THE-ART FACILITIES, TECHNOLOGY, MANAGEMENT, AND SUPPORT SERVICES. RESPONSIBILITIES OF LEADERSHIP: MEMORIAL SLOAN-KETTERING CANCER CENTER IS A LEADER IN CANCER RESEARCH AND TREATMENT, OFFERING PATIENTS THE MOST SOPHISTICATED, COMPASSIONATE, AND STATE-OF-THE-ART CARE AVAILABLE AND ADVANCING THE KNOWLEDGE THAT WILL IMPROVE THAT CARE IN THE FUTURE. THE CLOSE COLLABORATION BETWEEN OUR PHYSICIANS AND SCIENTISTS IS ONE OF OUR UNIQUE STRENGTHS, ENABLING US TO PROVIDE PATIENTS WITH THE BEST CARE POSSIBLE AS WE WORK TO DISCOVER MORE-EFFECTIVE STRATEGIES TO PREVENT, CONTROL, AND ULTIMATELY CURE CANCER. Form 990, Part III, Line 4a PATIENT CARE PATIENT CARE: MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERTS HAVE ESTABLISHED STANDARDS OF CARE AND TREATMENT PROTOCOLS FOR EACH TYPE AND STAGE OF CANCER. OUR PHYSICIANS HAVE AN EXTRAORDINARY DEPTH AND BREADTH OF EXPERIENCE IN DIAGNOSING AND TREATING ALL FORMS OF THE DISEASE, FROM THE MOST COMMON TO THE VERY RARE. EACH YEAR, THEY TREAT MORE THAN 400 DIFFERENT SUBTYPES OF CANCER. THIS LEVEL OF SPECIALIZATION CAN HAVE AN OFTEN-DRAMATIC EFFECT ON A PATIENT'S CHANCES FOR A CURE OR CONTROL OF THEIR CANCER. WHILE WE ARE KNOWN FOR OUR ADVANCED, INNOVATIVE THERAPIES, OUR PHYSICIANS ARE EQUALLY WELL REGARDED FOR THEIR COMPASSION AND CONCERN. OUR DISEASE MANAGEMENT PROGRAM FEATURES 16 MULTIDISCIPLINARY CANCER TEAMS. PATIENTS ARE TREATED BY AS MANY DIFFERENT SPECIALISTS AS ARE NEEDED FOR THEIR PARTICULAR TYPE OF DISEASE, INCLUDING SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, RADIOLOGISTS, PATHOLOGISTS, PSYCHIATRISTS, AND NURSES. OUR PATHOLOGISTS HAVE UNSURPASSED EXPERTISE IN USING ADVANCED METHODS TO ACCURATELY DIAGNOSE CANCER. BECAUSE OF THEIR SOLE FOCUS ON CANCER, OUR SURGEONS USE SURGICAL TECHNIQUES THAT PRESERVE FORM AND FUNCTION. OUR RADIATION ONCOLOGISTS ARE DEVELOPING AND PUTTING INTO CLINICAL PRACTICE LEADING-EDGE TECHNOLOGIES AND TECHNIQUES IN RADIATION THERAPY. IN ADDITION, THE CENTER OFFERS A FULL RANGE OF PROGRAMS TO HELP PATIENTS AND FAMILIES THROUGHOUT ALL PHASES OF TREATMENT, INCLUDING SUPPORT GROUPS, GENETIC COUNSELING, HELP MANAGING CANCER PAIN AND SYMPTOMS, REHABILITATION, INTEGRATIVE MEDICINE SERVICES, AND ASSISTANCE IN NAVIGATING LIFE AFTER TREATMENT. THROUGHOUT THE COVID-19 PANDEMIC AND BEYOND MSKCC CONTINUES TO WORK TO PROTECT AND ASSIST THE PUBLIC. CURRENTLY, THE INSTITUTION IS ACTIVELY MAINTAINING A POSTURE OF PREVENTION AND SAFETY, WITH ITS EDUCATION PROGRAMS WHILE ENCOURAGING PERSONS TO WEAR THEIR MASKS AND ADHERE TO OTHER PREVENTIVE MEASURES LIKE GETTING BOOSTER SHOTS. Form 990, Part III, Line 4b RESEARCH RESEARCH: MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. RESEARCH AT SLOAN-KETTERING INSTITUTE IS DEDICATED TO UNDERSTANDING THE BIOLOGY OF CANCER THROUGH PROGRAMS IN CELL BIOLOGY, ENETICS, BIOCHEMISTRY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, COMPUTATIONAL BIOLOGY, IMMUNOLOGY, AND THERAPEUTICS. INVESTIGATORS AT SLOAN-KETTERING INSTITUTE COLLABORATE WITH MEMORIAL HOSPITAL PHYSICIAN-SCIENTISTS, A PARTNERSHIP THAT HELPS SPEED IMPORTANT RESEARCH FINDINGS FROM THE LABORATORY TO THE BEDSIDE, IN A PROCESS KNOWN AS TRANSLATIONAL RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER ALSO ACTIVELY INITIATES AND PARTICIPATES IN CLINICAL TRIALS TO IDENTIFY MORE EFFECTIVE CANCER THERAPIES, AND OUR PHYSICIANS ARE CURRENTLY LEADING MORE THAN 1,900 CLINICAL TRIALS FOR PEDIATRIC AND ADULT CANCERS. THE HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM (HOPP) IS A FURTHER EFFORT TO INCREASE INSTITUTIONAL RESEARCH STRENGTH IN AREAS IMPORTANT IN CONTEMPORARY TRANSLATIONAL RESEARCH. HOPP IS DESIGNED TO MELD EVEN MORE THOROUGHLY THE CULTURES OF BASIC BIOLOGIC SCIENCE AND CLINICAL ONCOLOGY, AUGMENTING THE WORK CONDUCTED IN THE LABORATORIES OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S PHYSICIAN-SCIENTISTS. Form 990, Part III, Line 4c EDUCATION EDUCATION: EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR COLLABORATIONS WITH THE ROCKEFELLER UNIVERSITY, CORNELL UNIVERSITY, AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY OFFER PHD PROGRAMS IN CHEMICAL BIOLOGY, COMPUTATIONAL BIOLOGY AND MEDICINE, AND THE MEDICAL SCIENCES. THE CENTER ALSO PARTNERS WITH WEILL MEDICAL COLLEGE AND THE ROCKEFELLER UNIVERSITY TO OFFER A MD/PHD DEGREE FOR ASPIRING PHYSICIAN-SCIENTISTS. THE CENTER HAS A PHD PROGRAM IN CANCER BIOLOGY THROUGH ITS LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS NOVEL PROGRAM HAS BEEN ENROLLING STUDENTS SINCE 2006 AND TRAINS BASIC LABORATORY SCIENTISTS TO WORK IN RESEARCH AREAS DIRECTLY RELEVANT TO CANCER AND OTHER HUMAN DISEASES. WE ALSO OFFER POSTGRADUATE CLINICAL FELLOWSHIPS TO TRAIN PHYSICIANS WHO SEEK SPECIAL EXPERTISE IN A PARTICULAR TYPE OF CANCER AND POSTGRADUATE RESEARCH FELLOWSHIPS THAT PROVIDE PHYSICIANS AND SCIENTISTS WITH ADVANCED LABORATORY RESEARCH TRAINING. WITH FACULTY APPOINTMENTS AT THE WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY, OUR CLINICAL STAFF ALSO TRAIN RESIDENTS AND MEDICAL STUDENTS. Form 990, Part VI, Line 15 A & B MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC) IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE MSKCC BOARD OF TRUSTEES AND GOVERNING TRUSTEES HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED ENTIRELY OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARD TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS MARCH 2024, WHICH SET THE COMPENSATION FOR THE PERIOD APRIL 2024 TO MARCH 2025. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS COMMITTEE MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958. - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. Form 990, Part VI, Line 2 Family/business relationships amongst interested persons DIRECTORS ELLEN V. FUTTER AND RICHARD I. BEATTIE - Business relationship Form 990, Part VI, Line 6 Classes of members or stockholders THE ARTICLES OF INCORPORATION AND BY-LAWS WERE REVIEWED TO DETERMINE THAT THE SUPPORTED ORGANIZATIONS OUTLINED IN SCHEDULE-A HAVE THE POWER TO ELECT OR APPOINT MEMBERS TO THE BOARD OF THE SUPPORTING ORGANIZATIONS. MEMORIAL SLOAN-KETTERING CANCER CENTER, EIN 13-1924236, (MSK), IS THE SINGLE MEMBER OF THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM LLC, PCCTC, WHICH HAS ELECTED TO BE TREATED AS A DISREGARDED ENTITY OF MSK FOR TAX PURPOSES AND MSKCC PROTON, INC. WHICH IS ALSO TREATED AS A CORPORATION FOR TAX PURPOSES. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES EIN 13-1624082, (MEM), IS THE SINGLE MEMBER OF MSKCC PROPERTIES LLC, WHO HAS ELECTED TO BE TREATED AS A CORPORATION FOR TAX PURPOSES. Form 990, Part VI, Line 11b Review of form 990 by governing body PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE SR. VP OF FINANCE AND THE INTREM CHIEF FINANCIAL OFFICER. IT IS THEN PRESENTED TO, AND REVIEWED BY, THE JOINT AUDIT COMMITTEE OF THE BOARD. THE JOINT AUDIT COMMITTEE REFERS THE FORM 990 TO THE FULL BOARD, AND A COPY IS PROVIDED TO EACH BOARD MEMBER FOR FURTHER REVIEW. MEMORIAL SLOAN-KETTERING'S FORM 990 IS REVIEWED BY COUNSEL AND IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. Form 990, Part VI, Line 12c Conflict of interest policy 1. Conflict of Interest and Commitment Policy (the "Individual COI Policy"). a. The Individual COI Policy applied to: (i) physicians and scientists with academic appointments at any level; (ii) any clinical provider who could independently write orders or prescriptions; (iii) individuals whose roles included the design, conduct or reporting of research and/or were engaged in human subject research; (iv) administrative employees with independent authority to make purchasing decisions or who were otherwise able to bind, negotiate on behalf, or execute agreements on behalf of, MSK; and (v) individuals that served on MSK institutional committees with responsibility for oversight of research, formulary, or purchasing decisions. b. MSK's Compliance COI Office ("Compliance") and the institutional conflict of interest committee (the "MSK COI Committee") were responsible for the administration of this policy, under the oversight of the committee of the Board (the "Board COI Committee") dedicated exclusively to discharging the Board's responsibility and authority over MSK's conflicts of interest program. c. Upon becoming covered by the Individual COI Policy, annually thereafter and/or as new significant interests arose, an individual was required to disclose financial interests and external relationships and activities ("interests"), whether paid or unpaid, that reasonably appeared to be related to the individual's institutional responsibilities. Covered Persons were required to disclose interests for themselves and immediate family members. d. Depending on the circumstances and based on established criteria, disclosed interests were reviewed by Compliance, the MSK COI Committee, MSK COI Committee designee(s), and/or the Board COI Committee to determine whether an individual conflict of interest existed or presented the perception thereof (i.e. whether an individual financial interest could directly and significantly impact an individual's institutional responsibilities, or an individual's interest could be directly and significantly impacted by their institutional responsibilities). e. The policy required any individual conflict of interest to be managed, reduced or eliminated. When a conflict of interest determination was made, the MSK COI Committee, the MSK COI Committee designee(s), or the Board COI Committee, as applicable, determined how to address it. For those conflicts deemed manageable, management strategies implemented included disclosure of the interest in relevant publications, presentations, consent forms, and educational materials; recusal and/or other limitation on role; independent oversight by a disinterested senior personnel member or committee; and temporary or permanent reduction, divestiture, relinquishment, or termination of an individual's interest. 2. Institutional Conflict of Interest Policy (the "Institutional COI Policy"). a. The Institutional COI Policy applied to financial interests and relationships ("interests") held by MSK as an institution, as well as those financial interests and relationships ("interests") held by senior executive officers deemed "Institutional Officials, their immediate family members. b. Institutional interests held by MSK were made available to Compliance through regular reports from and ongoing engagement with relevant MSK departments. Institutional interests held by Institutional Officials were disclosed through the process described above in the Individual COI Policy, as well as the process described below in the Board COI Policy. c. The MSK COI Committee or MSK COI Committee designee(s) were responsible for determining whether an institutional conflict of interest existed; i.e. whether the institutional interest held by MSK or an Institutional Official (or their immediate family members) could, or could reasonably be perceived to, directly and significantly affect the design, conduct, reporting, review, or oversight of MSK research or the outcome of an MSK activity or decision. d. The policy required any institutional conflict of interest to be managed, reduced or eliminated. When an institutional conflict of interest determination was made, the MSK COI Committee and/or the MSK COI Committee designee(s) determined how to address it. For those conflicts deemed manageable, management strategies implemented included recusal of the applicable Institutional Official from decision-making regarding the arrangement and disclosure to relevant personnel; disclosure of the interest in relevant publications, presentations, consent forms, and educational materials; independent oversight by a disinterested senior personnel member or committee; and temporary or permanent reduction, divestiture, relinquishment, or termination of MSK's or an Institutional Official's institutional interest. 3. Boards of Governing Trustees Conflict of Interest Policy (the "Board COI Policy"). a. The Board COI Policy applied to Board members, officers, and other MSK senior leadership. Individuals covered by the Board COI Policy were required to disclose financial interests and relationships, as defined by the policy, annually and on an ongoing basis. Other entities in the same tax-exempt group had overlapping officers and Board members as described in Schedule O; such persons reported financial interests through this or related processes. b. The Board COI Committee was responsible for determining whether any interest disclosed under the Board COI Policy gave rise to a conflict of interest. The policy required that the members of the Board COI Committee vote, without the individual with the potential conflict present, to determine whether a conflict of interest existed. All members participating in the vote were required to be disinterested with respect to the transaction, arrangement, or relationship. c. The covered individual with the conflict of interest could make a presentation to the Board COI Committee, but could not participate in or influence the discussion of, or vote on, the proposed transaction, arrangement, or relationship. The existence and resolution of any conflict of interest, along with associated determinations made and votes taken, were required to be documented in writing. d. For any transaction, arrangement, or relationship that involved a conflict of interest, a conflict management plan could be implemented if doing so was in the best interests of MSK. Management plans could require disclosure, recusal or other limitation of role, independent oversight and confidentiality. Form 990, Part VI, Line 19 Required documents available to the public THE INSTITUTION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. COPIES OF OUR IRS FORM 990, 990T AND OUR AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS, AND THE BOND OFFERING STATEMENTS FOR ALL OUR DEBT ISSUES ARE AVAILABLE ON THEIR WEB ADDRESS: WWW.DACBOND.COM. THE CONFLICT OF INTEREST AND COMMITMENT POLICY IS ACCESSIBLE ON OUR INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. HOWEVER, OUR GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT AVAILABLE FOR PUBLIC INFORMATION. Form 990, Part VII, Section A Board Member Listing THIS IRS FORM 990 IS FILED UNDER GROUP EXEMPTION NUMBER 3475, EIN 91-2154267. THE ATTACHED LIST REPRESENTS MEMBERS FROM THE GOVERNING BOARDS OF THE FOLLOWING AFFILIATED INSTITUTIONS THAT MAKE UP OUR EXEMPT GROUP: MEMORIAL SLOAN-KETTERING CANCER CENTER (MSK) EIN 13-1924236, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (MEM) EIN 13-1624082, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (SKI) EIN 13-1624182, S.K.I. REALTY, INC. (SKR) EIN 13-3389586, LOUIS V. GERSTNER JR. GRADUATE, SCHOOL OF BIOMEDICAL SCIENCES (SKG) EIN 20-2212588, MSK INSURANCE US, INC. (MSKI) EIN 83-0363317, AND MSKCC PROTON INC.,(MSKP) EIN 35-2397819. ALSO INCLUDED IN THE GROUP IS MSK PROPERTIES LLC. EIN 35-2464610 WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER. MEMORIAL SLOAN KETTERING BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE IAN COOK, VICE CHAIR OF THE BOARD. STANLEY F. DRUNCKENMILLER ANTHONY B. EVNIN ROGER W . FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V . GERSTNER, JR. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS, VICE CHAIR OF THE BOARD. RALPH MULLER JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON VIGINIA M. ROMETTY ALAN D. SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON STEPHEN SQUERI JOHN R. STRANGFELD SCOTT M. STUART, CHAIR OF THE BOARD. SELWYN M. VICKERS M.D., BOARD MEMBER AND CEO, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER. DOUGLAS A. WARNER III, HONORARY CHAIR OF THE BOARD. PETER A. WEINBERG 31 BOARD MEMBERS; 30 INDEPENDENT BOARD MEMBERS MEMORIAL HOSPITAL BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE, HONORARY CHAIR OF THE BOARD. IAN COOK, CHAIR OF THE BOARD. STANLEY F. DRUNCKENMILLER ANTHONY B. EVNIN ROGER W . FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V . GERSTNER, JR. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS RALPH MULLER JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON VIGINIA M. ROMETTY ALAN D. SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON STEPHEN SQUERI JOHN R. STRANGFELD SCOTT M. STUART SELWYN M. VICKERS M.D. , BOARD MEMBER AND CEO, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER. DOUGLAS A. WARNER III PETER A. WEINBERG 31 BOARD MEMBERS; 30 INDEPENDENT BOARD MEMBERS SLOAN KETTERING INSTITUTE BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE IAN COOK STANLEY F. DRUNCKENMILLER ANTHONY B. EVNIN ROGER W . FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V . GERSTNER, JR., HONORARY CHAIR OF THE BOARD. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS, CHAIR OF THE BOARD. RALPH MULLER JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON VIGINIA M. ROMETTY ALAN D. SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON STEPHEN SQUERI JOHN R. STRANGFELD SCOTT M. STUART SELWYN M. VICKERS M.D. , BOARD MEMBER AND CEO, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER. DOUGLAS A. WARNER III PETER A. WEINBERG 31 TOTAL BOARD MEMBERS; 30 INDEPENDENT BOARD MEMBERS S.K.I. REALTY BOARD OF DIRECTORS: LOUIS V . GERSTNER, JR. JAMES G. NIVEN CLIFTON S. ROBBINS SCOTT M. STUART, CHAIR OF THE BOARD. DOUGLAS A. WARNER III 5 BOARD MEMBERS; 5 INDEPENDENT BOARD MEMBERS GERSTNER GRADUATE SCHOOL BOARD OF TRUSTEES: GEOFFREY CANADA RICHARD I. BEATTIE ELLEN V. FUTTER LOUIS V. GERSTNER, JR. SHIRLEY JACKSON MARIE-JOSEE KRAVIS ALAN D SCHNITZER, CHAIR OF THE BOARD SCOTT M. STUART SELWYN M VICKERS MD, BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER 9 TOTAL BOARD MEMBERS; 8 INDEPENDENT BOARD MEMBERS MSK INSURANCE U.S. BOARD OF DIRECTORS: DEBRA BERNS, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER. STEPHEN C. SHERRILL, CHAIR OF THE BOARD. ANKIT CHHABRA, PRESIDENT, EMPLOYEE NOT AN INDEPENDENT BOARD MEMBER MICHAEL P. HARRINGTON, TREASURER. EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER. AARON BUNNER, VICE PRESIDENT, EMPLOYEE NOT AN INDEPENDENT BOARD MEMBER COLIN GARRY, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER. KATIE WELCH, SECRETARY 7 BOARD MEMBERS; 2 INDEPENDENT BOARD MEMBERS MSKCC PROTON INC., BOARD OF DIRECTORS: SHELLY ANDERSON, EMPLOYEE, NOT AN INDEPENDENT DIRECTOR. MICHAEL P. HARRINGTON, EMPLOYEE, NOT AN INDEPENDENT DIRECTOR. SIMON POWELL M.D., EMPLOYEE, NOT AN INDEPENDENT DIRECTOR. 3 BOARD MEMBERS; 0 INDEPENDENT BOARD MEMBERS Form 990, Part VII, Section B, Line 1 INDEPENDENT CONTRACTORS AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS PAID TO SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. Form 990, Part VIII, Line 11d Other Miscellaneous Revenue - Total Revenue: , Related or Exempt Function Revenue: , Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: ; Form 990, Part XI, Line 9 Other changes in net assets or fund balances Postretirement - -51828000; Other - -13171040; Total - -64999040; Schedule C, Part II-B THE ORGANIZATION ENGAGES IN FEDERAL, STATE, AND LOCAL LOBBYING. THE CENTER'S FEDERAL LOBBYING EFFORT FOCUSES ON PATIENT CARE AND REIMBURSEMENT ISSUES. PATIENT CARE ADVOCACY INCLUDES ENSURING PATIENTS ARE ABLE TO ACCESS CLINICAL TRIALS AND CANCER HOSPITALS ARE ABLE TO EFFECTIVELY RESEARCH POTENTIAL TREATMENTS FOR CANCER AS WELL AS PREVENTATIVE AND PALLIATIVE MEASURES. THE CENTER ALSO SEEKS EQUITABLE REIMBURSEMENT FOR SERVICES RENDERED TO PATIENTS ENROLLED IN ENTITLEMENT PROGRAMS. FROM TIME TO TIME, THE CENTER WEIGHS IN ON OTHER FEDERAL LEGISLATION THAT IMPACTS CANCER CARE AND HOSPITALS IN GENERAL. THE CENTER'S STATE LOBBYING EFFORTS FOCUS ON ISSUES RELATING TO PATIENT CARE, PUBLIC HEALTH, AND HOSPITAL OPERATIONS. PATIENT CARE AND PUBLIC HEALTH ISSUES MAY INCLUDE ACCESS TO CARE AND CANCER PREVENTION AND SCREENING, INCLUDING AS PART OF STATE BUDGET LEGISLATION. OUR ADVOCACY ON HOSPITAL OPERATIONS CENTERS ON ISSUES RELATING TO PROFESSIONAL LICENSURE AND CONTINUING EDUCATION, SCOPE OF PRACTICE, HOSPITAL STAFFING, AND HEALTH AND SAFETY REQUIREMENTS. ON OCCASION, THE CENTER ENGAGES IN LOCAL LOBBYING ON ISSUES RANGING FROM BUILDING ORDINANCES TO RADIATION CONTROL. THE CENTER ALSO INCURS COSTS FOR FEDERAL, STATE, AND LOCAL LOBBYING BY ASSOCIATIONS AND OTHER ORGANIZATIONS OF WHICH IT IS A MEMBER. Schedule F, Part V FOREIGN GRANTS AND INVESTMENTS MSKCC DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE OF THE UNITED STATES. ALL OF THE VALUES LISTED ARE AT COST, WITH THE EXCEPTION OF THE INVESTMENTS, WHICH ARE VALUED AT FAIR MARKET VALUE. PROSTATE CANCER CLINICAL TRIALS 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 22006000 9391000 MSKCC MSK ABC LLC 1275 YORK AVE NEW YORK NY 100656007 320752089 MSK Event Services NY 0 0 MSKCC MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501(c)(3) 10 MSKCC true TRI-INSTITUTIONAL THERAPEUTICS DISC INST 1300 YORK AVE NEW YORK NY 10065 463673346 MEDICAL RESEARCH EDUCATION DE 501(c)(3) Type I NA false MSKCC REGIONAL NETWORK 1275 YORK AVE NEW YORK NY 10065 020594889 HEALTH CARE NY MEM Related 13684308 0 false true 1 MEMORIAL RADIATION ONCOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133237927 HEALTH CARE NY MEM Related 52140551 0 false true 1.00 MEMORIAL DEVELOPMENTAL CHEMO GROUP 1275 YORK AVE NEW YORK NY 10065 133278548 HEALTH CARE NY MEM Related 6386997 0 false true 1 MEMORIAL MEDICAL CONSULTATION GROUP 1275 YORK AVE NEW YORK NY 10065 133278550 HEALTH CARE NY MEM Related 11718819 0 false true 1 MEMORIAL CARDIOPULMONARY GROUP 1275 YORK AVE NEW YORK NY 10065 133278552 HEALTH CARE NY MEM Related 6925147 0 false true 1 MEMORIAL CLINICAL PHYSIOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133278556 HEALTH CARE NY MEM Related 2594688 0 false true 1 MEMORIAL GASTROENTEROLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133278574 HEALTH CARE NY MEM Related 12489697 0 false true 1 MEMORIAL HEMATOLOGYLYMPHOMA GROUP 1275 YORK AVE NEW YORK NY 10065 133278575 HEALTH CARE NY MEM Related 26571015 0 false true 1 MEMORIAL SOLID TUMOR GROUP 1275 YORK AVE NEW YORK NY 10065 133278578 HEALTH CARE NY MEM Related 53115826 0 false true 1 MEMORIAL NUCLEAR MEDICINE GROUP 1275 YORK AVE NEW YORK NY 10065 133278580 HEALTH CARE NY MEM Related 13448067 0 false true 1 MEMORIAL DERMATOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133278581 HEALTH CARE NY MEM Related 9353455 0 false true 1 MEMORIAL INFECTIOUS DISEASE GROUP 1275 YORK AVE NEW YORK NY 10065 133278582 HEALTH CARE NY MEM Related 3530943 0 false true 1 MEMORIAL ENDOCRINE GROUP 1275 YORK AVE NEW YORK NY 10065 133278583 HEALTH CARE NY MEM Related 6033627 0 false true 1 MEMORIAL PULMONARY FUNCTION GROUP 1275 YORK AVE NEW YORK NY 10065 133304834 HEALTH CARE NY MEM Related 5429600 0 false true 1 MEMORIAL PEDIATRICS GROUP 1275 YORK AVE NEW YORK NY 10065 133346908 HEALTH CARE NY MEM Related 11592440 0 false true 1 MEMORIAL PATHOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133365998 HEALTH CARE NY MEM Related 71376529 0 false true 1 MEMORIAL ANESTHESIOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133367135 HEALTH CARE NY MEM Related 66373740 0 false true 1 MSKCC RADIOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133375559 HEALTH CARE NY MEM Related 108357589 0 false true 1 MEMORIAL NEUROLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133399377 HEALTH CARE NY MEM Related 16183783 0 false true 1 MEMORIAL PSYCHIATRY GROUP 1275 YORK AVE NEW YORK NY 10065 133430629 HEALTH CARE NY MEM Related 5089464 0 false true 1 MSKCC SURGERY GROUP 1275 YORK AVE NEW YORK NY 10065 134010372 HEALTH CARE NY MEM Related 193754522 0 false true 1 MEMORIAL SLOAN-KETTERING CANCER CENTER SUFFOLK AT HAUPPAUGE 1275 YORK AVE NEW YORK NY 10065 134059247 HEALTH CARE NY MEM Related 7186773 0 false true 1 MSK HARRISON 1275 YORK AVE NEW YORK NY 10065 300831483 HEALTH CARE NY MEM Related 17893978 0 false true 1 MSK MONMOUTH 1275 YORK AVE NEW YORK NY 10065 300937486 HEALTH CARE NY MEM Related 27800104 0 false true 1 MSK SURGERY NJ 1275 YORK AVE NEW YORK NY 10065 301138432 HEALTH CARE NY MEM Related 349725 0 false true 1 MSKCC CLINICAL PRACTICE PLAN 1275 YORK AVE NEW YORK NY 10065 510616510 HEALTH CARE NY MEM Related 15598943 0 false true 1 MSKCC INTEGRATIVE MEDICINE GROUP 1275 YORK AVE NEW YORK NY 10065 542092060 HEALTH CARE NY MEM Related 2202602 0 false true 1 MEMORIAL SLOAN-KETTERING CANCER CENTER AT BASKING RIDGE NEW JERSEY 1275 YORK AVE NEW YORK NY 10065 593801080 HEALTH CARE NY MEM Related 20294690 0 false true 1 MSK BERGEN 1275 YORK AVE NEW YORK NY 10065 611791803 HEALTH CARE NY MEM Related 21860044 0 false true 1 MSK NASSAU 1275 YORK AVE NEW YORK NY 10065 611904151 HEALTH CARE NY MEM Related 10384284 0 false true 1 MEMORIAL URGENT CARE GROUP 1275 YORK AVE NEW YORK NY 10065 651263291 HEALTH CARE NY MEM Related 10130176 0 false true 1 MEMORIAL CLINICAL GENETICS GROUP 1275 YORK AVE NEW YORK NY 10065 651263292 HEALTH CARE NY MEM Related 908634 0 false true 1 BTS LIQUIDATING LLC 1430 BROADWAY NEW YORK NY 10018 262602952 INVESTMENTS NY MEM Excluded false false 0.8 CHARITABLE REMAINDER TRUSTS (204) CHARITABLE REMAINDER TRUSTS NY NA Trust false TWO SIGMA US ALL CAP 89 NEXUS WAY CAMANA BAY GRAND CAYMAN CJ KY19007 INVESTMENT CJ MSK C Corporation 18363951 70934659 1 true AXAR OFFSHORE FUND LT PO BOX 309 UGLAND HOUSE GRAND CAYMAN CJ KY11104 INVESTMENT CJ MSK C Corporation 6133371 5537621 0.81 true PCM LONG OFFSHORE INVESTMENT MSK C Corporation 9566069 59566069 1 true false false false false false false false false false false false false false false false false true false false MEMORIAL MEDICAL CARE PC Q 3601411 COST